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ABSTRACT 
 
 At the intersection of materials chemistry and biology, biomaterials have been 
successfully employed in an array of medical applications. From diagnostic tools to 
targeted drug delivery, the modular physical and chemical properties of these materials 
provide numerous applications. For example, porous nanoparticles have been widely 
integrated as vehicles to carry chemotherapeutics to localized tumor sites. By 
encapsulating these cytotoxic compounds within a porous framework, the commonly 
associated adverse side effects of conventional chemotherapeutics, such as Doxorubicin, 
have been greatly reduced. One such material, mesoporous silica, has received 
widespread attention due to its excellent biocompatibility, high surface area to mass ratio, 
tunable pore diameters and volumes, and robust surface chemistry. However, recent 
studies have demonstrated that exposing silica nanoparticles, and other synthetic 
materials, to biological milieu envelops the particles in layers of proteins and 
biomolecules. The resulting protein coat, known as the ‘protein corona’, has been shown 
to have profound effects on bioavailability, cellular targeting, and cytotoxicity. Thus, in 
order to develop safe and effective particle-based therapies, it is of utmost importance to 
establish a more thorough understanding of this process. 
To examine how changes in surface chemistry influence protein adsorption, 
monodisperse, spherical mesoporous silica nanoparticles, ca. 50 nm, were modified with 
a variety of surface functionalizations, -NH2, -COOH, and -PEG. Exposing these 
materials to biological fluid revealed drastically different protein fingerprints, suggesting 
a strong correlation between the surface chemistry and the identity and composition of 
the protein corona. Quantification of the protein corona, i.e. mg protein/mg particles, was 
then achieved by performing thermogravimetric analysis. These values, in concert with 
spectral counts obtained by shotgun proteomics, illustrates a method for quantifying 
individual proteins present in the corona. 
 Spherical, silica particles of varying diameters, 70-900 nm, were then synthesized 
to investigate how particle diameter may affect the biomolecular identity of the protein 
corona. Applying the previously described methods, it was found that mesoporous 
particles exhibit a higher affinity for low-molecular weight proteins compared to dense 
silica particles of similar diameters.  
 Finally, stochastic optical reconstruction microscopy (STORM) was used to map 
protein adsorption/diffusion throughout as-prepared (pore diameter ~ 30 Å) .and large 
pore (pore diameter > 60 Å) mesoporous silica particles. By collecting three-dimensional 
data on the protein-adsorbed materials, a sphere-fitting algorithm could be applied to 
determine the center and radius of the host particle. This calculation demonstrated that 
the depth by which specific proteins diffused into the porous framework was a function 
of both the protein’s molecular weight as well as the pore diameter.  
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CHAPTER 1: INTRODUCTION 
 
1.1   Biomaterials 
At the convergence of materials science and medicine, biomaterials have not only 
advanced our fundamental understanding of human biology, but also played a critical role 
in developing safer and more effective medical treatments.  Defined as being a 
“nonviable material used in a medical device, intended to interact with biological 
systems,”1 this class of materials has grown to encompass a wide range of natural and 
synthetic scaffolds, such as polymers,2 ceramics,3 silica,4 hydrogels,5 among others. 
Commonly employed as therapeutic or diagnostic tools, biomaterials have experienced 
success in a range of fields: from dentistry to bone regeneration, the synthetic flexibility 
of biomaterials offers endless potential for medical applications. 
However, success of a biomaterial is dependent on a number of factors. 
Biocompatibility is of utmost importance upon exposing an engineered material to a 
biological system.6 Defined as the ability of a material to perform with an appropriate 
host response in a specific application, biocompatibility describes the capacity of a 
material to perform the desired application while limiting adverse side effects. In concert 
with biocompatibility, having adjustable biodegradability is also desirable. For example, 
in applying biomaterials to tissue regeneration or bone replacement, the ultimate goal is 
for native tissue and cells to replace the temporary scaffold.7 Additionally, these materials 
should exhibit flexibility in design and synthesis, offering tunability towards a desired 
application. For example, grafting targeting ligands or molecules onto the surface of a 
material may be accomplished through a number of chemical strategies. Thus, it is 
 2 
necessary for these materials to exhibit excellent and robust surface chemistry, allowing 
for post synthetic modification to enhance targeting and biocompatibility.  
Of the various applications using biomaterials, a wealth of research has focused 
on using synthetic materials for drug delivery. The bioavailability of a drug, defined as 
the percentage of drug that enters the blood stream, is largely dependent on the method of 
administration.8 For example, the commonly prescribed beta blocker, Propanolol, can 
exhibit as low as 25 % bioavailibiltiy when administered orally.9 This reduction in 
bioavailability is a consequence of first-pass metabolism, the process by which, following 
ingestion, the drug enters the hepatic portal system, passing through the liver before 
entering systemic circulation.10 During this process, a portion of the administered dose is 
metabolized by the liver and excreted from the body. To circumvent this reduction in 
available dose, intravenous (IV) injection is commonly employed. However, IV 
injections do not ensure premature activation of the compound or unintended interactions 
between the compound and peripheral sites.  On the other hand, it has been shown that 
biomaterials, such as mesoporous silica particles, can covertly transport a range of 
compounds to their intended physiological domain.11  
 
1.2   Biomaterials and Drug Delivery 
Exploiting biomaterials for drug delivery applications has received much interest 
in the last few decades.12-14 By encapsulating pharmaceutical compounds in porous and 
polymeric biomaterials, problems such as poor bioavailability, poor stability in aqueous 
systems, and peripheral interactions have been greatly improved.1,15 As previously 
 3 
mentioned, certain materials, such as silica, exhibit highly reactive surface chemistry. 
Post-synthetic modifications can be easily performed to graft any variety of ligands onto 
the surface, including antibodies and other targeting moieties such as folic acid16 and 
transferrin.17,18 Subsequently administering these materials to a biological system can 
direct the material towards its intended target. Ligand-receptor interactions ensure 
specificity to the desired cell or tissue, circumventing non-specific interactions with 
neighbouring domains.19 After being internalized into the target cell, various chemical 
and biological strategies, such as disulfide reduction,20 pH-dependent diffusion,21 and 
photoinduced release,22  can be used to excrete the drug from the porous support (Figure 
1.1).  
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Figure 1.1. Illustration of the Trojan horse model. Biomaterial, depicted as 
porous particle, interacts with cell membrane via targeting ligand or antibody. 
Once internalized, the molecular cargo is released and acts on its intended 
intracellular target.   
 
Numerous researchers have exploited this “Trojan horse” model over the years.23 
However, only recently have researchers begun to explore some of the fundamental 
biological mechanisms that govern transportation and distribution of materials in living 
systems.24 Of the various biological mechanisms intended to mitigate foreign bodies and 
organisms, protein adsorption has been shown to have a drastic effect on the 
physiological fate of an engineered material.25-27 When a foreign material or organism 
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enters the bloodstream, proteins and other biomolecules will rapidly adsorb onto the 
surface, an immunogenic process meant to mitigate the risk of invasion (Figure 1.2). For 
example, the adsorption of fibrinogen to a biomaterial can induce a conformational 
change in the protein, resulting in the exposure of two integrin binding domains. A 
consequence of this conformational rearrangement is that these integrin binding domains 
are capable of phagocyte activation.28 Subsequent phagocyte recruitment ensures that the 
foreign invasion is properly excreted and neutralized via the mononuclear phagocyte 
system (MPS).29 In the case of biomaterials, this process has been shown to be involved 
in transplant rejection,30 ineffective targeting,31 and increased cytotoxicity.32 
 
 
Figure 1.2. Exposing biomaterials, such as a spherical nanoparticle, to biological 
fluid envelops the particle in layers of proteins and biomolecules.   
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1.3   Protein Adsorption on Biomaterials 
 Protein adsorption onto solid surfaces has been well documented since the 1960s 
when Leo Vroman published his findings on the adsorption of common serum proteins 
onto a glass surface. In this seminal work, Vroman illustrated the propensity of plasma 
proteins to displace adsorbed fibrinogen.33 These findings suggested a competitive 
process in which high motility proteins, i.e. smaller proteins and highly abundant 
proteins, initially dominate the surface of a substrate, but are later displaced by low 
motility proteins that exhibit a higher affinity for the substrate surface. Since these initial 
findings, the Vroman Effect has been widely used to explain the formation of the protein 
‘corona’ on biomaterials such as nanoparticles.  
 
Figure 1.3. Illustration of the Vroman effect on nanoparticles. High motility 
proteins (blue) will adsorb onto the surface. Over time, low motility proteins 
(yellow) that exhibit a higher affinity for the material’s surface will displace the 
high motility proteins.  
 7 
The formation of the protein corona, the layers of proteins and biomolecules that 
interact with the surface of a nanoparticle following exposure to biological fluid, is an 
incredibly dynamic and complex process. Of the thousands of biomolecules identified in 
serum,34 each one may exhibit a certain adsorption (kon) and desorption (koff) rate for the 
surface; the equilibrium between these rates defines the binding affinity (Kd) of a protein 
for the nanoparticle.35 To describe each biomolecule’s binding affinity for a material’s 
surface would be nearly impossible given the complexity of this process. Rather, our 
current understanding of the protein corona is that it exists as two separate entities. The 
hard corona describes those biomolecules that strongly adhere to the particle surface. 
Interacting with this particle-protein complex is the soft corona, which is held in place by 
weak protein-protein interactions. Due to the instability of these interactions, the soft 
corona is said to be in constant exchange with the surrounding environment.36 A number 
of analytical methods have been developed for identifying and quantifying the hard 
corona. Gel electrophoresis, shotgun proteomics, and thermogravimetric analysis are a 
few of tools available to perform these functions. However, applying these 
methodologies to studying the soft corona is unfeasible, as the association between the 
soft and hard coronas is too fragile to withstand the harsh, and sometimes destructive, 
procedural conditions. Thus, to date, a majority of the research presented, including this 
work, deals with the hard corona.  
  To understand how this process influences the physiological state of synthetic 
materials in biological systems, researchers have explored how the physicochemical 
properties of various materials influence the formation of the protein corona. To date, a 
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number of physicochemical factors have been identified that shape the biological identity 
of the protein corona. Chemical composition, surface functionalization, size, shape, 
hydrophobicity/hydrophilicity, and porosity of the biomaterial are the most important 
contributing factors. However, among these properties, porosity remains one of the more 
challenging aspects to address due to the complexity in describing adsorption through a 
porous matrix. Additionally, given the widespread use of porous materials in the 
biomedical community, it is critical to develop a more thorough understanding of how 
porosity influences the adsorption of biomolecules. 
   
1.4   Methods for Studying Protein Adsorption 
The dynamics and identity of the protein corona have been probed with a variety 
of techniques. Illustrated by Cedervall and coworkers, the identity of the hard corona can 
be elucidated using shotgun proteomics.37 Changes in protein conformation have been 
observed using circular dichroism (CD),38 2D nuclear magnetic resonance spectrometry 
(2D-NMR),39 fluorescence correlation spectroscopy (FCS),40 and fourier transform 
infrared spectroscopy (FT-IR).41 Quantification of the protein corona relative to its 
substrate can be accomplished using both thermogravimetric analysis (TGA)42 and quartz 
crystal microbalance (QCM).43 Measuring changes in particle size and surface charge as 
a result of protein adsorption are conducted using dynamic light scattering (DLS).  
However, perhaps most important, the identification of the protein corona can be 
analysed by polyacrylamide gel electrophoresis (PAGE), and liquid spray 
chromatography – mass spectrometry (LC-MS/MS).44 Of those techniques listed, for the 
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presentation of this work, the use of gel electrophoresis, LC-MS/MS, DLS, and TGA will 
be thoroughly examined.  
 
1.4.1   Gel Electrophoresis 
The separation of complex protein mixtures is commonly accomplished by 
sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE). This technique 
uses an electric field to separate proteins on the basis of molecular weight as they pass 
through a gel matrix. Because lower molecular weight proteins will move faster towards 
the cathode than higher molecular proteins, this technique can be used to identify 
individual constituents in complex mixtures.45  
Typically, a sample containing the particle-protein mixture is treated with a thiol-
reducing agent and sodium dodecyl sulphate (SDS). This step induces a denaturation 
event, followed by the stoichiometric binding of SDS to the protein. Because each protein 
exhibits a unique chemical structure and therefore isoelectric point (pI), the binding of 
SDS imposes a negative charge to all proteins. Preparation of the porous matrix is 
accomplished by treating a polyacrylamide solution with ammonium persulfate (APS) 
and tetramethylethylenediamine (TEMED) to initiate the polymerization process. Once 
set, the gel is then placed upright in an electrophoresis chamber and the samples are 
distributed among the wells. Finally, the voltage and time are adjusted on the power 
supply depending on the desired separation. Once the sample has finished, the gel is 
stained to resolve individual bands. Due to the complexity of the samples presented in 
this work, ascribing proteins to individual bands has been avoided.  
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1.4.2   Shotgun Proteomics 
Recent advancements in processing power and proteomics have enabled 
researchers to extend the usage of LC-MS/MS beyond that of a few proteins. Now, 
analysis of complex mixtures, such as that of serum, can be easily conducted in a single 
run.46 As such, a new avenue has opened for understanding highly complex biological 
processes that were previously inaccessible.  
This technique relies on the removal of the protein corona through either chemical 
or physical means. Once isolated, the protein mixture is digested into shorter peptides 
using a protease, such as trypsin, to produce a peptide mixture. Following, the peptide 
mixture is separated by reversed phase liquid chromatography (LC). As the peptides elute 
from the column, they are ionized and separated by the mass spectrometer (MS1) based 
on their mass to charge (m/z) ratio. A second stage of mass spectrometry (MS2) is then 
used to separate these ions by fragmentation, usually by collision-induced dissociation, 
ion-trapping, or other methods  (Figure 1.4).47 Once the spectrum has been acquired, the 
fragmentation patterns are sequenced using the analysis program, SEQUEST. This 
software identifies amino acid sequences and compares them against those found in the 
database. Based on the percent identification for particular sequences, accuracy scores are 
provided for each identified protein. Proteins that score higher than a certain percentage 
are assumed to be accurate and considered for analysis.  
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1.4.3   Dynamic Light Scattering 
Analyzing the size distribution of nanoparticles and nanoparticle-protein 
complexes is performed using dynamic light scattering (DLS).48 While electron 
microscopy requires fixing a dry sample on a grid or embedding the sample in a resin, 
DLS is capable of measuring particle size in solution, an important facet when discussing 
biomedical applications. As particles are suspended in an aqueous solution, a monolayer 
of counter ions will adsorb onto the surface, known as the Stern layer. Silica, for 
example, which is negatively charged at physiological pH, will be surrounded by 
positively charged ions. Surrounding this layer is a diffuse layer that is composed of both 
cations and anions (Figure 1.5). Collectively, the particle with these adsorbed layers 
represents the hydrodynamic diameter,49 which can be calculated using the Stokes-
Einstein equation:50 
 𝐷! =  𝑘!𝑇3πη𝐷! (1.1) 
where DH is the hydrodynamic diameter of the particle, kB is the Boltzmann constant, T is 
the solution temperature, η is the dynamic viscosity of the fluid, and DT is the 
translational diffusion coefficient of the particles.  
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Figure 1.5. Illustration of how DLS measurements are made.  
 An additional component of dynamic light scattering is the ability to measure the 
electrokinetic potential of colloidal suspensions. This charge, known as the zeta-potential 
(ζ-potential), is a measure of the electric potential in the interfacial double layer between 
the slipping plane and a random point in the bulk solution (Figure 1.5). Using this 
technique provides information regarding the stability of the colloidal suspension (Table 
1.1).51 
 
Table 1.1. Stability of colloidal suspensions with relation to zeta potential.52 
Stability Characteristics Avg. Zeta Potential (mV) 
agglomeration and precipitation 0 to -10 
Threshold of agglomeration -10 to -15 
Threshold of moderate stability -16 to -30 
Moderate stability -31 to -40 
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1.4.4   Thermogravimetric Analysis  
 Quantification of the adsorbed protein layer relative to the mass of its substrate is 
performed using a technique known as thermogravimetric analysis (TGA). This 
analytical technique is commonly employed to measure the concentration of an organic 
species adsorbed or conjugated to inorganic nanoparticles, such as silica. To perform this 
method, sample is suspended in a pan connected to a high-precision balance. The sample 
is then enclosed in a furnace that allows for reactive gas, such as oxygen, to flow through 
the chamber. The temperature is then gradually increased to the desired temperature at a 
rate of 2 - 10 oC/min. Due to the difference in combustion temperatures between the 
organic species and the inorganic substrate, the change in weight is attributed solely to 
the loss of the organic component. Measuring the difference between the weight at 100 
oC and the temperature at which the identified species as been fully removed, the ratio of 
the organic component relative to silica can be calculated by Equation 1.2: 
 𝑤𝑡.% 𝑜𝑟𝑔𝑎𝑛𝑖𝑐 =  𝑋! − 𝑋!𝑋!  𝑥 100 (1.2) 
where X1 is the weight of the material at 100 oC, and X2 is the weight of the material 
following the decomposition of the organic species, usually around 600 oC. In the case of 
a known organic species, the mol organic/g silica can be calculated by multiplying the 
weight percent organic by the molecular weight of the known species, and dividing by 
the mass of silica used in the analysis.   
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1.5   Modeling Protein Adsorption on Particles 
 While many have identified and quantified the individual proteins in the protein 
corona, very few techniques have been described to investigate the spatial orientation of 
those proteins.53,54 Conformational changes in protein structure upon adsorption have 
been investigated by isothermal titration calorimetry,55 circular dichroism,56 2D-NMR,57 
and FT-IR.58 However, these techniques are unable to provide three-dimensional 
coordinates of those proteins relative to each other. Recently, Kelly and coworkers were 
able to devise a method for mapping protein-binding sites on transferrin(Tf)-coated 
polystyrene nanoparticles.59 This was accomplished using scanning TEM (STEM) and 
required the use of antibody-labeled gold nanoparticles. As presented by the authors, only 
a fraction of the adsorbed Tf was appropriately arranged for receptor binding, suggesting 
that corona formation is a stochastic process, whereby receptor binding sites may be 
obscured by the particle’s surface. An additional study by Miclăuş and coworkers 
explored spatial mapping of the soft and hard coronas on ~40 nm silver nanocubes using 
a combination of techniques, including transmission electron microscopy and localized 
surface plasmon resonance (LSPR).60 In this work, they discovered that both the soft and 
hard coronas exhibited time-dependent and concentration-dependent changes. 
Interestingly though, the authors discovered that regardless of time or serum 
concentration, the soft corona contained more protein than the hard corona. However, the 
aforementioned reports relied on the use of dense materials where the spatial localizations 
were constrained to the surface of the particles. The difficulty in extending these 
techniques to porous materials lies in the fact that protein adsorption in porous cavities is 
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a complex process, and requires the ability to image inside the material. Applying the 
aforementioned techniques to porous silica would not provide information about protein 
adsorption within pores. On the other hand, a fluorescence microscopy technique such as 
stochastic optical reconstruction microscopy (STORM) can be used to acquire three-
dimensional coordinates of the identified proteins adsorbed onto mesoporous silica, 
because it has the ability to provide well-resolved, 3D information about the interior of 
the particles.  
 
1.5.1   Stochastic Optical Reconstruction Microscopy  
In 1873, Ernst Abbe noted that the resolution of optical microscopy was limited 
by diffraction, a physical phenomenon that has plagued optical microscopy. Known as 
the Abbe diffraction limit, the best resolution achievable by traditional microscopy is 
governed by Equation 1.3.61 
 𝑑 =  0.5λ𝑛sinθ (1.3) 
 
where d is the resolution limit (nm), λ is the wavelength, n is the refractive index, and θ is 
the angle of the incoming light (Figure 1.6). Collectively, nsinθ is known as the 
numerical aperture (NA).  
Conversely, Rayleigh argued optical resolution was governed by the following 
equation:62 
 𝑑 =  0.61λ𝑛sinθ (1.4) 
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The primary difference between these two equations is their interpretation of 
“resolvable”. When light from all points of an object converges at the imaging plane, a 
blurry spot (“airy disk”) is produced as a result of diffraction. The three-dimensional 
intensity distribution of this spot is known as the point-spread function (PSF) (Figure 
1.6).63 Thus, if two objects are closer than the full width at half-maximum (FWHM) of 
the PSF, the relative positions of the objects cannot be resolved. This problem places a 
lower size limit on the features in a sample that can be resolved by common microscopy 
techniques. 
 
Figure 1.6. (a) Schematic diagram of fluorescence microscopy setup, and (b) a 
plot of the airy disk obtained following point source detection. Adopted from 
reference [64].  
 
Despite this limitation, fluorescence microscopy continued to be used as one of 
the primary tools for investigating biological structures and mechanisms. Techniques 
such as confocal laser scanning (CLSM) microscopy (Figure 1.7) slightly improved 
resolution by localizing the excitation light through a pinhole to a small area on the 
sample. Following sample excitation, fluorescence emission is focused through an 
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additional pinhole before reaching the detector. Thus, only molecules confined within the 
excited region are recorded, improving the signal to noise ratio by limiting background 
fluorescence and out-of-focus light. Additional improvements to image quality can be 
achieved through post-processing techniques such as deconvolution. Deconvolution is an 
algorithm-based process by which image distortion is removed to recover the signal of 
interest.65   
However, breaking the diffraction barrier was not achieved until the development 
of stimulated-emission-depletion (STED) fluorescence microscopy.66 This technique 
employed the use of a second laser to suppress the fluorescence emission from 
fluorophores surrounding the finite point of interest. This landmark achievement, which 
improved resolution by a factor of 4.5, offered insight into biological mechanisms and 
structures that were previously unobservable. Following the discovery of STED, many 
high-resolution fluorescence microscopy techniques have been developed that operate on 
the principle of saturable depletion.   
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Figure 1.7. Representative comparison between CLSM and STED microscopy. 
HeLa cells stained with primary antibodies against the nuclear pore complex 
protein Nup153 and secondary antibodies conjugated with ATTO647N. Adapted 
from reference [62]. 
 
An alternative approach to breaking the diffraction barrier was developed 
independently by researchers in 2006.67,68 In contrast with the previously developed 
methods that required the addition of a second laser to suppress fringe fluorescence, these 
techniques introduced the idea of photoactivated fluorescent probes. By implementing 
fluorescent probes that could switch between excited and dark states, thousands of frames 
could be collected to temporally resolve the locations of individual fluorescent markers 
(Figure 1.8).  
 
 20 
 
Figure 1.8.  Illustration of the principle used to generate super resolution images 
by STORM and PALM. Adapted from reference [63]. 
 
Additionally, these techniques do not require the use of additional hardware; the 
improvement in resolution is achieved through post-acquisition processing performed by 
the software. While both of these techniques employ similar methods, stochastic optical 
reconstruction microscopy (STORM) was optimized for fluorescent dyes whereas 
photoactivated localization microscopy (PALM) was developed for imaging 
endogenously expressed fluorescent protein. Figure 1.9 shows a comparison of wide-
field microscopy compared to that of PALM/STORM.  
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Figure 1.9. Comparison between widefield total internal relfection fluorescence 
(TIRF) and PALM/STORM. TdEosFP-paxillin expressed in a Hep G2 cell to 
label adhesion complexes at the lower surface. Adapted from reference [62]. 
 
1.6   Silica Nanoparticles  
Biomaterials science encompasses a wide range of synthetic materials depending 
on the desired application. For theranostic purposes, dense and porous silica have been 
widely used due to their biocompatibility, ease of synthesis and modification, and 
physicochemical stability. The Stöber process, discovered by Werner Stöber in 1968, has 
been used to construct and model a variety of nanoparticles.69 In this process, 
tetraethylorthosilicate (TEOS) is treated with a mixture of water, alcohol, and ammonia. 
According to the aggregation growth model, hydrolysis of TEOS under basic conditions 
affords silicic acid monomers, Si(OH)4. When the concentration of these monomers 
exceeds 0.02 – 0.03%, polymerization is initiated, producing both low and high 
molecular weight polymer chains. These polymers then collapse to form nuclei (1-2 nm) 
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of future particles. Condensation of silica polymers onto the surface of the nuclei initiates 
the growth process until a critical diameter of 5-7 nm is reached (primary particles). 
Finally, primary particles aggregate to form larger silica nanoparticles until electrostatic 
repulsion terminates the growth of the particle (Figure 1.10).70 
 
Figure 1.10. Scheme for the formation of silica via the Stöber process.   
 
Following this synthesis, Stöber demonstrated that monodisperse, sub-100 nm 
silica particles could be produced.69 While the practical biomedical usage of dense silica 
is limited in scope, this synthetic model was ultimately used to produce the first 
mesoporous silica particles. 
 
 23 
1.7   Mesoporous Silica Nanoparticles 
Of the naturally occurring porous materials, zeolites are perhaps the most well 
studied and recognized.71 Discovered in 1756 by Swedish mineralogist, Axel Cronstedt, 
zeolites are microporous aluminosilicate minerals. Their highly ordered, cage-like 
structures with numerous pores have long interested researchers due to their potential 
applications in molecular selectivity and separation.72 Yet, even within this broad class of 
materials, zeolites are limited by their structural properties, constrained to pore diameters 
less than 20 Å. Realizing the true potential of porous structures requires synthetic control 
over pore size, morphology, and composition.  
The first synthesis of materials with tunable pore sizes and shapes was reported in 
the early 1990s when researchers at ExxonMobil synthetically produced mesoporous 
silica with several phases, and pore between 20 and 100 Å.73,74 These materials, known as 
the ‘M41S’ family, resulted from efforts to produce synthetic zeolites that were capable 
of processing high molecular weight petroleum-based molecules.75 Of these materials, the 
highly ordered hexagonal material, Mobil Composition of Matter No. 41 (MCM-41) has 
been extensively studied and applied towards many fields of research.    
Mesoporous materials are typically synthesized via a surfactant-templated self-
assembly process.76 Under basic conditions, the hydrolysed silicate precursor condenses 
to form charged silica colloids. Solvated surfactant molecules, usually composed of an 
alkyl chain and terminal quaternary ammonium, will then interact with these charged 
silica species to self-organize into three-dimensional micelles. The interaction between 
neighbouring silica-micelle groups drives the formation of the final construct. By varying 
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the synthetic parameters, a variety of morphologies and mesostructures can be obtained. 
Finally, chemical or thermal removal of the surfactant affords the porous structure.  
 Owing to their large specific surface area, tunable pore volumes and pore size, 
particle morphologies, and physicochemical stability, this class of materials has been 
applied to numerous fields of research, from catalysis to medicine. In particular, these 
materials have been widely integrated into biomedical applications,77-79 behaving as 
carriers to deliver and release large amounts of biologically active compounds to 
physiological targets. Post-synthetic grafting of targeting ligands to the surface can also 
be achieved, increasing the localization potential and thereby reducing adverse side 
effects commonly associated with many therapeutics.80-82  
 
1.8   Characterization Methods for MSNs 
 Shape, size, and pore structure are critical in designing effective mesoporous 
materials for biomedical applications. Characterizing a material’s porosity, i.e. surface 
area, pore diameter and volume, is performed by nitrogen physisorption. Dispersity, size, 
and shape are characterized using electron microscopy and dynamic light scattering. 
Finally, thermogravimetric analysis is used to determine the fraction of organic material 
relative to the inorganic component after micellar templating.  
 
1.8.1   N2 physisorption 
Of the aforementioned characterization techniques, the most widely used, and 
perhaps most important, is nitrogen physisorption.83 This technique provides detailed 
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information about the porous properties of the material, i.e. the surface area (m2/g), pore 
volume (cm3/g), and pore diameter (Å). Physisorption is a process by which an adsorbate 
molecule, such as nitrogen, adheres to the surface of a solid material through van der 
Waals forces.   
A model for analyzing monolayer adsorption on a surface was first postulated by 
Irving Langmuir in 1916.84 Braunauer-Emmett-Teller theory (BET) extended this model 
to account for multilayer adsorption.85 To a sample tube containing the porous material, 
gaseous nitrogen is introduced at 77 K. Condensation onto the silica surface results in 
formation of the adsorbed monolayer. Initial formation of the monolayer occurs at low 
partial pressures (Figure 1.12). From this portion of the adsorption isotherm, the surface 
area can be calculated by using Equations 1.5 & 1.6. 
 
1𝑣[(𝑝!/𝑝)  − 1] =  𝑐 − 1𝑣!𝑐  𝑝𝑝! +  1𝑣!𝑐 (1.5) 
where po is the saturation pressure (the point at which the adsorbate, N2, is in equilibrium 
between the liquid and gas phase), p is the equilibrium pressure after dosing with a 
specific amount of gas, vm is the monolayer volume of adsorbed gas, v is the cumulative 
volume of dosed onto the sample, and c represents the BET constant. From this equation 
it can be seen that plotting 1/ 𝑣 !!!  − 1  versus  !!!  produces a straight line with 
slope and y-intercept equal to !!!!!! and !!!!, respectively (Figure 1.11).  
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Figure 1.11. Linear relationship used to determine the monolayer volume of 
adsorbed gas, vm.  
 
Obtaining vm from this plot allows the BET surface area to be calculated from the 
following expression, 
 𝑆!"# =  𝑣!𝑁𝑠𝑉𝑎  (1.6) 
where N is Avogadro’s number, s is the cross-section of the adsorbate (0.162 nm2 for N2), 
V is the molar volume of adsorbed gas, and a is the weight of the sample.  
 27 
 
Figure 1.12. Isotherm of mesoporous silica. At low partial pressures, nitrogen 
rapidly adsorbs to form a monolayer. Increasing the partial pressure continues to 
fill the mesopores, eventually reaching a plateau from which the pore size 
distribution can be calculated. Finally, pore saturation is reached from which the 
pore volume can be determined. The dashed lines highlight the hysterisis loop.    
 
Mesoporous materials also exhibit a capillary condensation point, from which the 
pore volume and pore diameter can be calculated. At this point, the N2 molecules no 
longer interact with the pore surface, so rapid condensation takes place. The volume of 
N2 required for this process is necessarily related to the diameter and volume of the pore. 
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Because the energy associated with adsorption and desorption from a mesopore differ, a 
hysteresis loop is observed provided that the pores are sufficiently larger (> 40 Å).  
 
1.8.2   Electron Microscopy  
 Particle size and shape are often characterized by both scanning and transmission 
electron microscopy (SEM/TEM). In SEM, a sample of the particles are suspended on 
carbon tape adhered to an aluminium stub. A conductive layer of gold/palladium is then 
sputter-coated onto the stub to enhance the topological features and inhibit charging and 
thermal damage. The sputter-coated sample is then placed on the instrument stage and 
subjected to vacuum. High-energy electrons are then accelerated towards the sample (20 
– 30 kV). These incident electrons are either then back-scattered or produce secondary 
electrons, which after interacting with the detector, produce a reconstructed three-
dimensional image.  This technique provides structural and morphological information of 
the material, with micrometer resolution (Figure 1.13a).86 
A similar preparation for TEM requires suspending the sample on a nickel or 
copper grid prior to analysis. After loading the sample into the instrument, high-energy 
electrons (80-100 kV) are focused on the sample. Because these electrons possess 
sufficient energy to pass through the material, an image with nanometer resolution is 
produced. In contrast with SEM, this technique provides incredibly detailed structural 
information, capable of imaging mesopores and channels (Figure 1.13b). Because it is a 
transmission-based process, areas of high density appear darker and areas of low density 
appear lighter in the final image.     
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Figure 1.13. (a) scanning and (b) transmission electron micrographs of 500 nm 
mesoporous silica nanoparticles. Inset of micrograph (b) shows detail of 
mesopores. Note difference in scale bars between images. 
 
1.9   The Formation of the Protein Corona on Biomaterials 
 As previously mentioned, the formation of the protein corona is highly dependent 
on the physicochemical properties of the substrate material. Of the properties identified to 
influence this process, particle size, surface chemistry, and pore diameter will be 
investigated throughout this work. 
 
1.9.1   The Effect of Particle Diameter on the Formation of the Corona 
One of the major physical properties shown to affect both the identity and 
composition of the protein corona is nanoparticle diameter. For example, Lundqvist and 
coworkers studied adsorption patterns on polystyrene (PS) particles of 50 and 100 nm.87 
In addition to the as-prepared materials, -COOH and –NH2 surface-modified materials 
were also used for these studies. To elucidate the importance of particle size, the ratio of 
plasma to surface area was held constant for all adsorption experiments. Interestingly, for 
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all materials, the total protein concentration (mg protein/m2 PS) increased up until a 
certain point (~250 µL), at which point the total amount of adsorbed protein significantly 
decreased (Figure 1.14). However, increasing the plasma concentration beyond this 
threshold demonstrated that, once again, the total amount of adsorbed protein increases. 
The driving force behind this ambiguity, as suggested by the authors, is possibly due to 
complex associative fluid phenomena.  
 
Figure 1.14. An example showing the effect of increasing plasma volume on 50 
nm PS-COOH nanoparticles.87 
A comparison of corona composition indicated that the 50 and 100 nm bare polystyrene 
nanoparticles exhibited ~80 % homology, suggesting that the synthetic identity has a 
greater effect on the protein corona than particle size in this case.  However, for the 
carboxylated materials, only 50 % homology was observed, signifying that particle size 
and surface composition are linked. It should be noted that, based on DLS measurements, 
the amine-modified particles presented high degrees of aggregation, making the 
comparison to other materials particularly challenging. A comparison between surface 
modifications within a given particle size revealed that ~35 % homology was found for 
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both particle sizes, concluding that both size and surface chemistry may have an 
incredible impact on the biomolecular corona.  
 Another example illustrating the effect of particle diameter on the formation of 
the protein corona was published by Tenzer et. al.88 For this study, quantitative 
proteomics analysis was to used to investigate the protein corona on amorphous silica 
particles of 20, 30, and 100 nm.88 Unlike the aforementioned study by Lundqvist and 
coworkers, the ratio of plasma proteins exceeded the surface area of the nanoparticles in 
an effort to mimic biological conditions. Following proteomic analysis, 46 proteins were 
identified that were significantly affected by changes in particle diameter. Investigating 
the physiological relevance of these 46 proteins revealed stark differences in 
concentrations between each particle population. For instance, the smaller particles of 20 
and 30 nm showed increased levels of complement proteins, a marker which is known to 
promote phagocytosis. Apolipoproteins, which are actively involved in lipid and 
cholesterol transport, were found in higher concentrations on the smaller particles. 
Biomolecules associated with blood coagulation were also affected by changes in particle 
size, where the 100 nm particles exhibited more than 5 fold increases in some proteins 
relative to the smaller samples.  
 
1.9.2   The Effect of Surface Chemistry on the Formation of the Corona 
 An additional study from Tenzer and coworkers investigated the temporal 
evolution of the protein corona on positively- and negatively-charged polystyrene 
nanoparticles (pPsNPs and nPsNPs, respectively) as well as silica nanoparticles of 
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various sizes (35 nm, 120 nm, 140 nm), charge, and surface modification (unmodified, 
amine, and carboxylate).89 Nanoparticle-protein complexes were rapidly isolated via 
centrifugation through a sucrose cushion; this allowed for rapid removal of loosely bound 
proteins (soft corona) while maintaining the hard corona. Surprisingly, over 166 different 
proteins were identified in the corona on both PsNPs and 30 nm SiNPs at 0.5 min. 
Temporal proteomic analysis was then conducted on all samples. Most important, 
bioinformatics analysis of the proteomic data revealed that the protein fingerprint was 
established at the earliest time point (0.5 min) for all samples; the only significant change 
was in the quantity of each residing protein. This finding opposes previous reports 
suggesting that the protein corona is dynamic and changes in both identity and 
composition over time. In support of the Vroman effect, concentration changes in groups 
of proteins were temporally observed; however, the complexity of the binding kinetics 
cannot solely be explained by the Vroman effect.  Certain groups of proteins, the authors 
noted, were abundant at early and late time points, but found in low concentrations in 
intermediate time points. Conversely, other groups of proteins showed the opposite 
behavior with concentrations peaking at intermediate time points. Additionally, the 
authors found proteins > 60 kDa constituted a majority of the corona on all samples.  
 This work was also extended to in vitro studies to examine the pathobiological 
role of the PC on human thrombocytes. Thrombocytes, in concert with other coagulation 
factors, aggregate to inhibit bleeding.90 Intriguingly, evidence for nanoparticle-induced 
aggregation has been observed in multiple systems.91,92 Upon exposure to bare silica 
nanoparticles, thrombocyte activation was rapidly observed. Conversely, nanoparticles 
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previously exposed to plasma proteins did not initiate thrombocyte activation, indicating 
that the protein corona plays a critical role in nanoparticle pathobiology.  
 The aforementioned materials, polystyrene and silica, have been widely used in a 
number of biomedical applications and are present in many consumer products. Other 
biomaterials, such as gold and carbon, have also received widespread interest for their 
potential medical usage. Gold nanoparticles, in particular, are an attractive material for 
cancer therapy due to their unique optical properties such as surface plasmon resonance 
(SPR).93 Interactions with incident light produce electronic oscillations in the gold 
nanoparticle; when these surface oscillations match the frequency of the incident light, 
surface plasmons are produced. This process can be used to generate heat at the 
nanoparticle surface, cleaving surface-bound DNA94 or even killing neighboring cancer 
cells. The effectiveness of this process is a direct consequence of nanoparticle size. But 
much like the previously described materials, proteins and biomolecules rapidly adhere to 
the surface of gold nanoparticles. Thus, to examine the relationship between nanoparticle 
size and the PC, Dobrovolskaia et al synthesized 30 nm and 50 nm colloidal gold 
nanoparticles and exposed them to human blood.95 Gel electrophoresis was then 
performed to separate the individual components of the protein corona on each sample. 
Following band excision, proteomic analysis identified 21 and 45 unique proteins on the 
30 and 50 nm particles, respectively. Of the 14 proteins common to both samples, 
fibrinogen was identified as the major component on both materials. Similar to the 
proteomic results for the 20 and 30 nm silica particles described earlier, both gold 
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samples adsorbed complement C3. Thus, one might infer that smaller particles (< 50 nm) 
are more likely to bind complement factors than larger particles.  
 
1.10   The Formation of the Protein Corona on Mesoporous Silica Nanoparticles 
Investigations on the adsorption of serum proteins onto porous materials are 
significantly fewer in number than those on dense materials. As a consequence, protein 
adsorption onto porous nanoparticles is less well understood. While it has been shown 
that the protein coronas on porous and nonporous silica nanoparticles are quite 
different,96,97 the driving forces behind this ambiguity remain undefined. For example, 
Lehman and coworkers recently investigated protein adsorption on mesoporous and 
nonporous amorphous silica nanomaterials of ~50 nm.96 By employing circular dichroism 
(CD) spectroscopy to assess conformational changes in the adsorption of bovine serum 
albumin (BSA), the authors observed severe loss of the albumin α-helix character upon 
adsorption to both the porous and nonporous material, suggesting that the adsorption 
process induces a denaturation event. Furthermore, quantification of albumin adsorption 
(molecules of BSA/g material) by TGA revealed that the bare mesoporous material 
adsorbed more than three times as much BSA compared to the bare nonporous material, a 
consequence of albumin molecules diffusing into the pores as speculated by the authors. 
However, additional studies were not conducted in order to determine if, in fact, the 
albumin molecules were able to diffuse into the pores.  
 Similarily, Ma and coworkers studied the adsorption of fibrinogen, albumin, and 
globulin onto small- and large-pore mesoporous silica particles of ~70 nm.98 Using 
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infrared (IR) spectroscopy, adsorption-induced changes in protein conformation were 
studied. Significant changes in conformation were observed for fibrinogen and albumin. 
However, globulin retained its native conformation following adsorption to the 
mesoporous materials. The authors attribute this behaviour to the size and rigidity of 
globulin compared to that of albumin and fibrinogen.  
 
1.11   Physiological Effects of the Protein Corona 
Predicting the biological outcome of particle-protein complexes is yet another 
major challenge in designing particle-based therapies. It has been demonstrated that the 
formation of the protein corona can affect targeting strategies, cytotoxicity, as well as in 
vivo retention time. For example, using transferrin (Tf)-functionalized silica 
nanoparticles, Salvati and coworkers demonstrated that the presence or absence of the 
protein corona had a direct effect on targeting capabilities.99 It was shown that while 
grafting transferrin onto the surface of silica nanoparticles retained its functionality, in 
the presence of serum proteins, recognition of the corresponding Tf receptor (TfR) 
diminished drastically.  Furthermore, internalization efficiency of silica nanoparticles in 
different cell lines has been connected to the protein corona.100 Importantly, however, the 
vast majority of these studies were limited to sub-100 nm particles. Furthermore, many of 
the comparison studies were conducted on a single type of silica material (i.e. porous, 
nonporous, amorphous, crystalline, surface-functionalized), making it challenging to 
evaluate how the physicochemical properties of silica particles govern this process.  
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1.12   Aim of this Work  
The aim of this work is to investigate how the physicochemical properties of 
dense and mesoporous silica nanoparticles influence protein adsorption from biological 
fluids. In particular, the roles of surface chemistry, particle diameter, and pore size will 
be thoroughly probed using a number of analytical techniques. Protein composition will 
be elucidated using gel electrophoresis, TGA, and proteomics. Spatial assignment will be 
determined using STORM in combination with least squares fitting. A number of 
publications have demonstrated that these materials are applicable towards biomedical 
procedures. However, it is now fundamentally necessary to develop a more thorough 
understanding how protein adsorption may contribute to the success or failure of silica 
particle-based therapies.  
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CHAPTER 2. EFFECT OF SURFACE PROPERTIES IN PROTEIN 
CORONA DEVELOPMENT ON MESOPOROUS SILICA 
NANOPARTICLES 
 
2.1   Introduction 
Nanomedicine is continuously providing new single and multifunctional 
alternatives to traditional pharmaceutical delivery and treatment, enhancing both 
therapeutic activity and selectivity to pathological tissues, as well as providing molecular 
recognition and biosensing features.1,2 Unfortunately, the stability of most nanomaterials 
in biological fluids is still a challenge to be solved, and the incorporation of stable 
nanoparticles into the bloodstream provokes a strong reaction with serum proteins, lipids, 
and small molecules, forming a shell of aggregated compounds known as the protein 
corona.3 The very high surface to volume ratio of nanomaterials dramatically boosts the 
adsorption process, changing their surface properties. This corona defines the biological 
identity of the nanomaterials and determines their final physiological fate. In the case of 
intravenous (iv) injection, protein adsorption drives nanoparticle uptake by monocytes 
and macrophages, leading to their distribution to the reticuloendothelial system (RES) 
and compromising their therapeutic efficacy.4-7 
Independent of the nature of the nanomaterial, the protein corona grows in a few 
minutes over the particles and may evolve for several days.8-10  It has a complex 
composition, often consisting of several dozens of proteins. Some of these proteins are 
loosely bound to particle surface (the “soft corona”), but, so far, most of the studies of 
this coating have been carried out over a short list of proteins firmly attached to particles 
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forming the “hard corona”, as this represents the protein signature of the nanomaterial in 
a given environment.11-15 These studies have shown that the total protein concentration in 
biological fluids may change the composition of the corona, although, surprisingly, the 
concentration of a specific protein does not determine its presence in the biological layer 
(e.g., human serum albumin is the most abundant protein in serum but is actually in 
minority around nanoparticles).16,17 Moreover, the role of targeting molecules decorating 
the nanoparticle surface depends on this protein covering, as the interaction with specific 
receptors may be seriously hindered.18 
 Changing nanoparticle properties, such as material,16 size,12,19,20 and surface 
chemistry,12,21,22 may alter the corona composition. Interestingly, the most widely applied 
strategy to block nonspecific protein adsorption on nanoparticles is to modify the surface 
by grafting linear chains of poly(ethylene glycol) (PEG).21,23 In fact, different studies 
support that PEGylation of nanomaterials diminishes interaction with serum proteins, 
decreasing the rate of phagocytic uptake and increasing blood residence time.24,25 
Additionally, proteomics analysis has been performed on a wide range of organic and 
inorganic nanomaterials, such as polystyrene,11,15,16 hydrogels,22 carbon nanotubes,26 
gold,9,21 SPIONs,27 quantum dots,28,29 and amorphous silica nanoparticles.16,17,19,20,22 
However, so far, no investigation has been reported on the protein corona on mesoporous 
silica nanoparticles (MSNs). In recent years, mesoporous silica materials have been 
considered to be excellent platforms for drug delivery systems.30-33 The large internal 
porosity of MSNs favors the loading of significant quantities of therapeutic molecules 
within the pore channels. Furthermore, nanoparticle shape and size, as well as pore 
 45 
structure, can be easily tuned through various synthetic strategies.34,35 Finally, the silanol-
containing surface can be easily functionalized, introducing additional features that allow 
for stimuli-responsive controlled drug release.36 Shi et al37 highlighted the effect of 
PEGylation of MSNs on human serum albumin binding and cellular responses, 
concluding that PEG grafting greatly decreased protein binding to MSNs as well as 
macrophage uptake. Nevertheless, additional work is needed to completely characterize 
the protein corona on MSNs, and how it evolves as a function of nanoparticle 
modification.  
In the present work, we have carried out a complete compositional study of the 
protein corona adsorbed onto 50 nm MSNs after incubation (1 h) in Dulbecco’s Modified 
Eagle’s Medium (DMEM) containing 10% fetal bovine serum (FBS). A proteomic 
analysis using one-dimensional sodium dodecyl sulfate-polyacrylamide gel 
electrophoresis (SDS-PAGE) and electrospray liquid chromatography mass spectrometry 
(LC-MS/MS) has been performed on the protein extract isolated from reacted 
nanoparticles. Quantitative results for most abundant proteins have been obtained by 
comparing proteomic distribution with thermogravimetric analysis (TGA) data. 
Furthermore, we have also investigated the influence of particle surface modification on 
the protein adsorption process by studying amine and carboxylate-modified MSNs, and 
we have used different chain length PEG molecules in order to evaluate the effect of 
PEGylation on particle reactivity.  
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2.2   Experimental Section 
 
2.2.1   Materials and Methods 
All reagents were provided by Sigma-Aldrich. N-hydroxysuccinimide esters of 
methoxy group-terminated polyethylene glycol molecules with FW = 333.33 (PEG3) or 
FW = 1214.39 (PEG24) were purchased from Iris Biotech.  
 
2.2.2   Synthesis of 50 nm MSN and Surface Modification 
A standard method with some modifications was used for the synthesis of 
unmodified MSN (MSN-OH).38 Briefly, 1.00 g of hexadecyltrimethylammonium 
bromide (CTAB) was dissolved in 500 mL of NaOH 14 mM at 80 ºC with strong stirring. 
Then, 5.0 mL of tetraethyl orthosilicate (TEOS) was dropped slowly. The obtained gel 
was 1:0.12:0.31:1245 SiO2/CTAB/NaOH/H2O. After 2 h, the resulting mixture was 
cooled in ice, filtered off and washed with water and methanol. The solid was dried at 
100 ºC overnight and heat-treated at 540 ºC for 6 h in air. 
Amine derivatized MSN (MSN-NH2) were prepared by surface functionalization 
of MSN-OH with 3-aminopropyltriethoxysilane (APTES). 500 mg of particles was dried 
at 350 ºC and vacuum (8 torr) for 3 h. Subsequently, 20 mL of anhydrous toluene was 
added and the mixture was heated to reflux. Then, 975 µL of APTES (4.2 mmol) was 
added and the mixture was stirred for 3 h. The obtained product was filtered off, washed 
with toluene and methanol and freeze-dried (-55 ºC, 16 h). 
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To obtain MSN with a coating of carboxylic moieties attached to surface (MSN-
COOH), 500 mg of particles MSN-OH was dried at 350 ºC and vacuum (8 torr) for 3 h. 
Afterwards, 5 mL of anhydrous toluene was added and the mixture was heated to reflux. 
Then, 40 µL of (3-cyanopropyl)-trichlorosilane (0.25 mmol) was added and the mixture 
was stirred for 3 h. The obtained product was filtered off, washed with toluene and 
methanol and dried at room temperature and vacuum for 16 h. This solid was dispersed in 
75 mL of sulfuric acid (60%) and heated at 150 ºC for 3 h in a reflux system. Then, the 
acid suspension was diluted with 100 mL of distilled water, filtered off, washed with 
toluene and methanol and freeze-dried (-55 ºC, 16 h). 
For preparation of PEG-derivatized nanoparticles 200 mg of MSN-NH2 was 
suspended in 20 mL of anhydrous dichloromethane. Then, 250 mL of diisopropyl amine 
were injected under nitrogen atmosphere. Afterwards, 150 mg of PEG3 or 500 mg PEG24 
was added. The reaction was stirred overnight at room temperature. Afterwards, the 
solvent was removed under reduced pressure and the nanoparticles were suspended in 
100 mL of ethanol by stirring. Later, the suspension was filtrated off and washed with 
ethanol (300 mL). Finally, the material was freeze-dried (-55 ºC, 16 h). 
 
2.2.3   Nanoparticle Characterization 
Nanoparticle morphology and size were studied by transmission electron 
microscopy (TEM) in a JEOL JEM 2100F microscope operating at 200 kV (Figures 2.1 
and 2.2). Samples were dispersed in methylene chloride and transferred to carbon coated 
copper grids. Nitrogen gas adsorption isotherms were measured in a Micromeritics 
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Flowsorb apparatus. Surface area calculations were carried out using the BET method, 
whereas pore  size distribution was calculated according to the Kruk-Jaroniec-Sayari 
(KJS) estimation.39 Particle size and Z-Potential measurements were conducted by 
diffuse light scattering (DLS) in a Zetasizer Nano ZS (Malvern Instruments Ltd., 
Worcestershire, UK). Dried materials were re-suspended in deionized water at a 
concentration of 5 mg/mL and measurements were performed at 25 ºC. The mean 
hydrodynamic diameter was determined by cumulant analysis. Surface coverage of 
organic groups (R-NH2, R-COOH, R-PEG3-OCH3 and R-PEG24-OCH3) was calculated 
from carbon elemental analysis determination (FISONS, EA 1108 CHNS-O). The 
organic content on the different samples before and after protein adsorption was 
quantified by thermogravimetric analysis in a Mettler-Toledo TGA/SDTA 851e 
apparatus. 
 
Figure 2.1. TEM micrograph of as-synthesized MSN-OH material. The inset 
shows the internal hexagonal order of a single 50 nm nanoparticle.  
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Figure 2.2. TEM micrograph of as-synthesized MSN-PEG3-OCH3 material. High 
mesoporous order and nanoparticle dispersion is observed even after 
functionalization. 
 
 
2.2.4   Protein adsorption 
Protein adsorption was achieved by incubating MSNs (1 mg) in 10% FBS/DMEM 
(1 mL) for 1 h at room temperature. Subsequently, the nanoparticles were isolated 
through centrifugation (14,800 rpm, 5 min) and the supernatant was discarded. The 
nanoparticles were then resuspended in PBS (1 mL) and sonicated.  This process was 
repeated three times in order to remove as much unbound protein as possible.  
 
2.2.5   SDS-PAGE 
One-dimensional sodium dodecyl sulfate-polyacrylamide gel electrophoresis was 
performed on the proteins isolated after serum incubation. Removal of the hard corona 
was achieved by sonicating nanoparticles in Laemmli buffer (63 mM Tris-HCl, pH 6.8, 
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40 mM DTT, 0.01% (w/v) bromophenol blue, 10% glycerol, 2% (w/v) SDS). Following, 
nanoparticle suspensions were boiled for 5-10 min in a hot water bath. Nanoparticles 
were then removed from the suspension through centrifugation (14,800 rpm, 5 min) and 
the supernatant was saved for SDS-PAGE analysis. Protein separation was then 
performed on a Bio-Rad Mini-PROTEAN electrophoresis system (120 V, 1.5 h). The 
gels were then stained for 2 h using GelCode blue stain reagent (Thermo Scientific), 
followed by de-staining overnight in deionized water.  
 
2.2.6   Protein quantification by bicinchoninic acid (BCA) test  
The hard corona was removed by sonicating the nanoparticles in extraction buffer 
(63 mM Tris-HCl, pH 6.8, 40 mM DTT, 10% glycerol, 2% (w/v) SDS). Nanoparticle 
suspensions were boiled for 5-10 min in a hot water bath; the nanoparticles were then 
removed from the suspension by centrifugation (14,800 rpm, 10 min). The supernatant 
containing the digested peptide (10 µL) was added to BCA reagent (200 µL taken from a 
solution of 4 mL 4% BCA, pH 8.5 and 80 mL of 4% CuSO4.5H2O) and the mixture was 
incubated at 37 ºC for 30 min. Next, absorbance at 562 nm was measured in a Nanodrop 
ND spectrophotometer. Calibrates were prepared with a protein standard solution 
(QuantiProTM BCA Assay Kit, Sigma-Aldrich). Total protein content quantified in the 
hard corona of MSN-OH, MSN-NH2 and MSN-COOH materials is presented in Table 
2.1. 
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Table 2.1. Comparison of protein quantification by thermogravimetric analysis 
(TGA) and BCA assay.  
Sample TGA (wt% organic) BCA (% protein) 
MSN-OH 10.1 8.8 
MSN-NH2 14.4 13.2 
MSN-COOH 2.3 3.2 
 
2.2.7   Protein digestion for mass spectrometry analysis  
After removal of the final PBS wash, nanoparticles containing the hard corona 
were suspended in digestion buffer (36 µL, 50 mM ammonium bicarbonate, 0.25 mM 
urea, 4% acetonitrile) and reducing buffer (6 µL, 100 mM dithiothreitol in H2O). These 
nanoparticle suspensions were allowed to incubate for 1 h at 70oC. After 1 h, alkylation 
buffer (15 µL, 100 mM iodoacetamide) was added and the samples were incubated at 
room temperature for 20 min in a dark place. Protein digestion was achieved by adding 
trypsin (15 µL, 40 ng/µL) and incubating overnight at 37oC. The following morning, 
formic acid (15 µL, 10%) was added to stop the digestion process. Prior to submitting the 
samples for proteomics analysis, the nanoparticles were centrifuged out of solution and 
the supernatant was submitted for analysis.  
 
2.2.8   Proteomics analysis method 
The digested peptide sample was desalted using a ZipTip C18 (P10, Millipore 
Corporation, Billerica, MA) according the manufacturer’s protocol, and then dried in a 
SpeedVac. The dried peptide samples were dissolved in 20 µl 0.1% formic acid and 2% 
acetonitrile, and 5 µl were loaded onto a fused silica microcapillary LC column (12 cm x 
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100 µm inner diameter) packed with C18 reversed-phase resin (5 µm particle size; 20 nm 
pore size; Magic C18AQ, Michrom Bioresources Inc.). Peptides were separated by 
applying a gradient of 3-60% acetonitrile in 0.1% formic acid at a flow rate of 250 
nL/min for 45 min. Nanospray ESI was used to introduce peptides into a liner ion trap 
(LTQ)-Orbitrap mass spectrometer (Thermo Fisher Scientific) via a nanospray ionization 
source. Mass spectrometry data was acquired in a data-dependent acquisition mode, in 
which an Orbitrap survey scan from m/z 400-2000 (resolution: 30,000 FWHM at m/z 
400) was paralleled by 10 LTQ MS/MS scans of the most abundant ions. After an LC-
MS run was completed and spectra were obtained, the spectra were searched against the 
IPI Bovine protein sequence databases (V 3.85) using Proteome Discoverer software 
(version 1.4; Thermo Electron, San Jose, CA). The search parameters permitted a 20 ppm 
precursor MS tolerance and a 1.0 Da MS/MS tolerance. Oxidation of methionine (M) and 
carboxymethylation of cysteines (C) were allowed as variable modifications. Up to two 
missed tryptic cleavages of peptides were considered. The cutoffs for SEQUEST 
assignments were: cross-correlation (Xcorr) scores greater than 1.9, 2.5, and 3.0 for 
peptide charge states of +1, +2, and +3, respectively; and a delta-correlation (∆Cn) score 
> 0.1. Then, all .srf files for each sample were inputted into Scaffold (version 
Scaffold_4.0.5, Proteome Software Inc., Portland, OR) for the calculations of total 
spectrum counts. 
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2.3   Results and Discussion 
 Highly ordered mesoporous silica nanoparticles (MSNs) were synthesized, with 
BET surface area about 700-900 m2 g-1. These MSNs were then used as the base material 
for further modifications (Figure 2.3).  
 
Figure 2.3. Synthesis scheme for the materials used in these experiments. 
 
The surface areas decreased slightly upon modification with amino- and carboxylate-
silanes; however, the modification of the MSNs with PEG chains severely reduced the 
surface area. This is most likely due to surface shielding and pore blocking effects, 
consistent with the fact that the surface area for the material modified with a short PEG 
chain (241 m2/g) was higher than for the long PEG chain (55 m2/g).  MSNs with average 
diameters of 50-55 nm (Figures 2.1 & 2.2) were obtained with low polydispersion, as 
characterized by transmission electron microscopy (TEM) and dynamic light scattering 
(DLS) techniques. Interestingly, the MSNs did not show significant changes in diameter 
as measured by DLS after exposure to 10% FBS solution, in contrast with the results of 
Monopoli et al. who described a 8-12 % increase in the hydrodynamic diameter of 
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amorphous silica nanoparticles after protein adsorption.16 However, the latter study used 
much larger particles (~200 nm), which likely led to different amounts of protein being 
adsorbed.20 
Analysis using TGA, confirmed with elemental analysis, showed that the as-made 
materials (surface-modified but not yet exposed to protein) contained varying weight 
percentages of organic material. The total organic content of the amine- and carboxylate-
modified MSNs was lower than that of the PEGylated MSNs, but this was primarily due 
to the increased mass of the PEG silanes. When calculated as mmol silane/g MSN, the 
trend is reversed, with more of the smaller silanes than the PEGs, which is consistent 
with the fact that the smaller silanes are able to access and modify the internal pore 
surfaces, while the larger PEG silanes primarily modify the external surface and the 
mouths of the pores, as described above. Finally, when the moles of each silane are 
scaled according to the available surface area (SBET), which is more consistent with the 
portion of the MSN that interacts with the protein solution, the values of µmol/m2 are 
nearly the same, indicating that the surface coverages are similar regardless of the type of 
modification. 
 The base material had a zeta potential of -12.4 mV, which is consistent with a 
bare silica surface in solution. Modification with amine groups led to a less negative zeta 
potential (-7.9 mV) due to the protonation of amines in the neutral solution used for 
measurement; the fact that the value is not positive indicates that the surface has not been 
completely modified. Similarly, MSNs modified with PEG chains showed less negative 
zeta potentials due to the two-step process used to attach the PEG chains, which involved 
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first modifying the surface with amines followed by reaction with N-hydroxysuccinimide 
(NHS)-modified PEG3 or PEG24. Thus the zeta potentials of the PEG-modified MSNs 
reflect the fact that both silanol and amine groups remain on the surface in addition to 
PEG. As expected, modification with carboxylate groups led to a more negative zeta 
potential (-15.4 mV).   
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Upon exposure to 10% FBS solution, the zeta potentials of the unmodified, -NH2 
modified, and –COOH modified MSNs became substantially less negative, consistent 
with the formation of a protein corona. The corona led to a shielding effect that altered 
the surface charge of the particles, which has been reported by other authors using 
different materials.9,22 In the case of the PEGylated MSNs, there was no significant 
change in zeta potential and therefore surface charge, leading to the conclusion that no 
significant protein corona had been formed. This was confirmed using thermogravimetric 
analysis (TGA) on MSNs before and after exposure to 10% FBS. Unmodified and –NH2 
modified MSNs showed significant amounts of adsorbed protein (10.1 and 14.4 wt %), 
with a lesser amount of protein adsorbed by the –COOH modified MSNs (2.3 wt%). In 
contrast, PEGylated MSNs showed no significant protein adsorption. Previous studies 
used long PEG chains,23,26,37 but we show here that even a PEG trimer was sufficient to 
prevent the formation of a protein corona. This is relevant to the use of porous 
nanoparticles, because the decrease in surface area and therefore the extent of pore 
blockage was much smaller for –PEG3 than for –PEG24 modified MSNs. 
The protein corona on each type of MSN in these studies was characterized by 
combining LC-MS and TGA data. Protein was released from the particles for analysis 
using a typical denaturation process (see Experimental Section). The amount of protein 
released by this technique was consistent with the TGA data, as confirmed by the 
bicinchoninic acid (BCA) assay. While other studies have shown the wide range of 
proteins that adsorb onto the surfaces of various types of nanoparticles, most of these 
results have been presented in terms of relative amounts of each. For example, Monopoli 
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et al.16 applied a normalization to the spectral counts obtained from LC-MS data that took 
into account the molecular weight of each protein, but this does not describe the mass of 
each adsorbed protein. Consequently, in these studies, spectral counts from LC-MS 
experiments were normalized to obtain the relative percentages of each protein on the 
surface, and this value was then multiplied by the weight of protein determined by TGA 
to obtain the mass of each adsorbed protein (Equation 2.1). 
 
𝑆𝑝𝐶!𝑆𝑝𝐶!!!  𝑥 𝑇𝐺𝐴 𝑥 10  (2.1) 
 
In this equation, SpCi is the spectral counts associated with a particular protein, 
and TGA is the weight percent of adsorbed protein in the particular MSN sample. The 
factor of 10 is added to bring the units to mg protein per g of particles. The first part of 
the equation is defined as normalized spectral counts, abbreviated NSpC. SpC values and 
a heat map of the complete set of adsorbed proteins for unmodified, –NH2 modified, and 
–COOH modified MSNs are, respectively, shown in Table 2.3 and Figure 2.4. 
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Table 2.3. Spectral counts (SpC) of each identified protein. Values are listed as 
the sum of triplicates for each sample. 
Protein 
Mw 
(kDa) 
MSN-
OH 
MSN-
NH2 
MSN-
COOH 
MSN-
PEG3 
MSN-
PEG24 
50 kDa protein 50 0 2 0 0 0 
ACTA2 protein-like 26 16 0 3 0 0 
Actin, alpha skeletal muscle 42 16 0 7 0 0 
Actin, cytoplasmic 1 42 0 12 0 0 0 
Alpha-1-antiproteinase 46 8 7 18 0 0 
Alpha-1B-glycoprotein 54 0 0 0 0 0 
Alpha-2-antiplasmin 55 0 7 0 0 0 
Alpha-2-HS-glycoprotein 38 59 73 17 6 0 
Alpha-2-macroglobulin 168 7 22 27 0 0 
Antithrombin-III 52 0 3 0 0 0 
Apolipoprotein A-I 30 42 10 30 0 0 
Apolipoprotein A-I-like 24 22 0 12 0 0 
Apolipoprotein A-II 11 28 41 17 0 0 
Apolipoprotein A-IV 43 0 0 0 0 0 
Apolipoprotein C-III 11 5 6 0 0 0 
Apolipoprotein E 36 0 11 3 0 0 
Apolipoprotein M 21 0 8 0 0 0 
Beta actin 42 0 0 2 0 0 
Beta-2-glycoprotein 1 38 0 0 6 0 0 
CCP modules 3-12, with parts of CCP 2 
and 13-like, partial 
37 0 0 0 0 0 
Clusterin 51 4 19 15 0 0 
Coagulation factor X 55 0 12 0 0 0 
Coagulation factor XII 67 0 0 0 0 0 
Collectin-43 34 0 17 0 0 0 
Complement C3 (Fragment) 187 4 61 2 0 0 
Complement component 8, alpha 
polypeptide 
66 0 0 2 0 0 
Complement factor H 140 0 0 3 0 0 
Complement factor H-like 106 0 0 0 0 0 
Complement factor H-like 65 0 0 0 0 0 
Complement factor H-like, partial 73 0 0 0 0 0 
Complement factor H-related 1-like 
isoform 1 
59 0 0 0 0 0 
Complement factor I 69 0 0 9 0 0 
ECM1 protein 58 0 3 3 0 0 
Embryo-specific fibronectin 1 transcript 262 0 38 11 0 0 
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Protein Mw 
(kDa) 
MSN-
OH 
MSN-
NH2 
MSN-
COOH 
MSN-
PEG3 
MSN-
PEG24 
variant 
Factor XIIa inhibitor 52 0 5 0 0 0 
Fetuin-B 43 3 2 0 0 0 
Fibrinogen alpha chain 67 12 9 8 0 0 
Gelsolin 81 0 0 16 0 0 
Hemoglobin fetal subunit beta 16 12 10 33 0 0 
Hemoglobin subunit alpha 15 0 13 4 0 0 
Hemoglobin subunit beta 16 10 0 17 0 0 
Histidine-rich glycoprotein 62 0 0 5 0 0 
Histidine-rich 
GLYCOPROTEIN=FACTOR XIIIA 
substrate (Fragment) 
24 0 3 0 0 0 
Hyaluronan-binding protein 2 62 0 7 0 0 0 
IGL@ protein 25 0 7 0 0 0 
Inter-alpha-trypsin inhibitor heavy chain 
H1 
101 0 13 0 0 0 
Inter-alpha-trypsin inhibitor heavy chain 
H3 
100 0 30 0 0 0 
Inter-alpha-trypsin inhibitor heavy chain 
H4 
102 12 0 44 0 0 
Isoform HMW of Kininogen-1 69 0 0 0 0 0 
Isoform HMW of Kininogen-2 69 0 20 0 0 0 
Isoform LMW of Kininogen-1 48 0 23 0 0 0 
Inter-alpha-trypsin inhibitor heavy chain 
H2 
106 0 88 8 0 0 
Periostin 93 0 6 0 0 0 
Pigment epithelium-derived factor 46 0 0 3 0 0 
Pregnancy-zone protein-like 159 0 0 2 0 0 
Protein AMBP 39 0 46 0 0 0 
Prothrombin (Fragment) 71 0 0 0 0 0 
QSOX1 protein 63 12 0 2 0 0 
Serum albumin 69 0 77 14 0 0 
Similar to complement component 4A 193 0 64 8 0 0 
Talin-1 270 0 8 2 0 0 
Tenascin-X 447 0 0 0 0 0 
Tetranectin 22 2 0 5 0 0 
Thrombospondin-1 130 12 0 4 0 0 
Uncharacterized protein 163 0 0 25 0 0 
Uncharacterized protein 78 16 27 13 0 0 
Uncharacterized protein 161 0 12 3 0 0 
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Protein Mw 
(kDa) 
MSN-
OH 
MSN-
NH2 
MSN-
COOH 
MSN-
PEG3 
MSN-
PEG24 
Uncharacterized protein 193 0 60 5 0 0 
Uncharacterized protein 47 0 0 5 0 0 
Uncharacterized protein 39 0 0 6 0 0 
Uncharacterized protein 33 0 0 0 0 0 
Uncharacterized protein 52 0 13 0 0 0 
Uncharacterized protein 55 0 9 0 0 0 
Uncharacterized protein 87 0 2 0 0 0 
Uncharacterized protein 303 0 7 0 0 0 
Uncharacterized protein 516 0 4 0 0 0 
Uncharacterized protein 52 0 0 2 0 0 
Uncharacterized protein (Fragment) 174 0 0 3 0 0 
Uncharacterized protein (Fragment) 176 0 0 8 0 0 
Uncharacterized protein (Fragment) 46 0 0 2 0 0 
Vitamin D-binding protein 53 0 11 0 0 0 
Vitamin K-dependent protein S 75 0 13 0 0 0 
Vitronectin 54 0 13 10 3 0 
von Willebrand factor 308 0 16 0 0 0 
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Figure 2.4. Heat map of all identified proteins, organized by increasing molecular 
weight. In this figure, color corresponds to NSpC × TGA. The highest value in is 
in green, the value at 50% is gold, the lowest value is in white, and all other 
values are colored on a linear scale between these values.  
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Figure 2.4 (continuued). Heat map of all identified proteins, organized by 
increasing molecular weight. In this figure, color corresponds to NSpC × TGA. 
The highest value in is in green, the value at 50% is gold, the lowest value is in 
white, and all other values are colored on a linear scale between these values.  
 
A subset of the most common proteins, defined as those with NSpC × TGA of 3.00 or 
higher, is shown in Table 2.4. It is apparent that although many proteins are present in 
10% FBS, the subset of adsorbed proteins in each type of MSN's hard corona is much 
smaller.  
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Table 2.4. Most common proteins found on porous 70 nm nanoparticles with 
various surface modifications.aMSN-PEGn-OCH3 materials did not show a weight 
loss from TGA and are not included here. Colors indicate relative amounts of 
each protein. bNSpC = normalized spectral counts from LC-MS, calculated as 
described in the text. cNSpC × TGA = amount of each protein found on particle, 
expressed as mg protein per g particles. 
     MSN-OH MSN-NH2 MSN-COOH 
Protein Mw (kDa) pI NSpC
b NSpC ×TGAc NSpC 
NSpC 
×TGA NSpC 
NSpC 
×TGA 
Apolipoprotein A-II 11 8.10 0.248 25.1 0.194 27.9 0.140 3.21 
Apolipoprotein C-III 11 5.11 0.044 4.48 0.028 4.08 0.000 0.00 
Hemoglobin subunit a 15 8.44 0.000 0.00 0.045 6.48 0.024 0.55 
Hemoglobin fetal subunit b 16 7.03 0.073 7.39 0.032 4.67 0.186 4.29 
Hemoglobin subunit b 16 6.74 0.061 6.16 0.000 0.00 0.096 2.21 
Apolipoprotein A-I-like 24 5.43 0.089 9.03 0.000 0.00 0.045 1.04 
ACTA2 protein-like 26 5.24 0.060 6.06 0.000 0.00 0.010 0.24 
Apolipoprotein A-I 30 5.97 0.137 13.8 0.017 2.49 0.090 2.08 
Collectin-43 34 5.12 0.000 0.00 0.026 3.74 0.000 0.00 
a-2-HS-glycoprotein 38 5.50 0.151 15.3 0.100 14.4 0.040 0.93 
Protein AMBP 39 7.62 0.000 0.00 0.061 8.82 0.000 0.00 
Actin, a skeletal muscle 42 5.23 0.037 3.75 0.000 0.00 0.015 0.35 
LMW Isoform of Kininogen-1 48 6.62 0.000 0.00 0.025 3.58 0.000 0.00 
Serum albumin 69 6.18 0.017 1.71 0.058 8.34 0.018 0.42 
Prothrombin (fragment) 71 6.33 0.000 0.00 0.041 5.90 0.000 0.00 
Inter-a-trypsin inhibitor heavy chain H2 106 7.94 0.000 0.00 0.043 6.21 0.007 0.16 
  
 
      total protein deposit from TGA 
(wt%)      10.1   14.4   2.3 
 
 
 More than 86 wt% of the adsorbed proteins was accounted for by only eight 
proteins (highlighted in Table 2.4) in the unmodified MSN sample, and the same proteins 
accounted for more than 60 wt% in the –COOH modified MSN sample although the total 
amount of adsorbed protein was significantly less. The zeta potential of the surface did 
not appear to be a significant factor in determining the type of protein adsorbed, because 
the isoelectric points (pIs) of the adsorbed proteins varied between 5.1 and 8.1. The pI 
values of most of the proteins are below 7, so they are negatively charged at 
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physiological pH. However, deposition on negatively charged nanoparticles does not 
correlate with protein charge, showing that electrostatic effects alone are not the major 
driving force regulating MSN-protein interactions. This is consistent with the 
composition of the protein corona on other particles.20,40 However, it is interesting to note 
that the molecular weights of these eight proteins were among the smallest of the entire 
set of identified proteins, with weights all below 38 kDa (Table 2.4 and Figure 2.5).  
 
Figure 2.5. Protein composition was grouped according to molecular weight 
range depicted in histogram. As shown, low molecular weight proteins composed 
the highest weight percentage of the protein corona.  
 
Because these samples all had large internal surface areas, there may be a size-exclusion 
effect in which larger proteins are prevented from adsorbing in large amounts by the 
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diameter of the pores. This makes sense in light of other studies of the protein corona on 
dense (non-porous) silica, in which a larger fraction of the adsorbed proteins had higher 
molecular weights. In the case of –NH2 modified MSNs the protein distribution is more 
varied. The eight proteins highlighted in Table 2.4 only account for 37 wt% of the total 
amount of adsorbed protein, and more proteins with higher molecular weights were 
adsorbed. Again, pI does not appear to play an important role here. The reason for this 
discrepancy could be in the dominant role of surface primary amines in the nonspecific 
binding of serum proteins on nanoparticles, as has been described in the literature.41,42 
Additionally, as noted above, the larger surface area of the –NH2 modified MSNs 
indicate that the pore surfaces are more accessible to proteins, which may allow a wider 
variety of low molecular weight proteins to be trapped in the pores. Finally, PEGylated 
samples did not show any protein adsorption by LC-MS or TGA, even in the case of –
PEG3 modified particles with surface areas of 241 m2/g. This confirmed the ability of 
PEG chains to prevent protein adsorption and therefore to prevent nanoparticle 
aggregation in biological medium. 
 
2.4   Conclusions 
In conclusion, we have characterized protein adsorption onto mesoporous silica 
nanoparticles (MSNs) modified with –NH2, –COOH, –PEG3, and – PEG24 groups as well 
as onto unmodified MSNs, using LC/MS-MS and TGA to determine the total mass of 
each protein adsorbed. The results are somewhat different from other studies performed 
on dense (non-porous) silica nanoparticles. Most of the adsorbed proteins had low 
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molecular weights, and the –NH2 modified MSNs had the largest variety of proteins. The 
pI values of the adsorbed proteins were mostly below physiological pH (7.4), although 
there was not a strong correlation between pI and the type of surface modification. 
Finally, PEGylated particles did not adsorb protein, regardless of chain length. 
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CHAPTER 3. PROTEIN CORONA ANALYSIS AS A FUNCTION OF 
PARTICLE DIAMETER 
 
3.1   Introduction 
 The integration of nanotechnology and medicine has become widespread over the 
last two decades, with several integrated systems currently in clinical trials.1,2  Inhibitor-
loaded nanomaterials may be decorated with a multitude of targeting ligands, limiting the 
adverse side effects commonly observed due to the interaction of systemically-
administered chemotherapeutics with normal cells. Of these materials, nano- and 
microparticles have received a great deal of attention due to their ease of construction and 
modification, biocompatibility, and uniform molecular adsorption and release kinetics.3,4 
However, in order to realize the true potential of these particle-based platforms, it is 
important to understand the properties of the nano-bio interface.  
 One of the greatest challenges currently hindering the advancement of these 
particle-based therapies occurs when particles are initially exposed to biological fluid.5  
In this environment, proteins and receptors will bind to the surface of the material, which 
can induce an immunogenic response,6,7 a complex process that has only recently been 
examined in relation to particle-based therapies.8 The proteins and biomolecules 
associated with particles after exposure to the biological fluid, collectively termed the 
‘protein corona’, have been shown to strongly adhere to the surface.9-11 The protein 
corona evolves both temporally and spatially.12-14 As illustrated by Barrán-Berdón et al, 
"burst" adsorption, a period of rapid initial adsorption, results from proteins and 
biomolecules that are in high concentration and possess a strong affinity for the particle 
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surface.12 Over time, equilibrium is reached as proteins at lower serum concentrations 
slowly exchange onto the particle surface. Thus, one could envision a competition for the 
particle surface, where each protein or molecule exhibits a unique equilibrium constant. 
Dynamic light scattering (DLS) studies have indicated that the protein corona is 
composed of both a hard inner layer, containing strongly adsorbed proteins with slow 
exchange rates, and a soft outer layer, containing proteins that exchange more rapidly and 
frequently. To date, analysis of the protein corona has primarily been conducted on the 
hard layer, that is, the layer of proteins remaining after the soft layer has been removed 
through washing. However, recently, Sakulkhu and coworkers were able to isolate the 
soft corona on iron oxide nanoparticles using magnetic and column separation.15 The 
properties of this particle-protein complex are responsible for effects on surrounding cells 
and tissue, rather than the native particle.  
It is now widely accepted that the physicochemical properties of engineered 
particles greatly influence the composition of the protein corona.16,17 Size, shape, ζ-
potential ("zeta" potential, related to nanoparticle surface charge in solution), and surface 
chemistry play a key role in the development and dynamics of the corona.18-20 The 
materials from which nanoparticles can be prepared, including lipids, silica, metal oxides, 
and various polymeric systems, each form a unique corona that depends on their chemical 
properties.18,21,22 In particular, porous and dense silica have received attention due to their 
biocompatibility and stability in a variety of biological systems.23,24 By controlling 
synthetic parameters, properties such as particle diameter, shape, and surface composition 
can be easily tuned for many biomedical applications. However, while many studies have 
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focused on silica nanoparticles (< 200 nm), larger particles (200 – 1000 nm) with the 
same composition and surface chemistry have been shown to exhibit different behavior in 
vitro and in vivo.25,26 In one example, an inverse correlation between particle size and 
cytotoxicity in HepG2 cells was observed, where smaller particles were found to be more 
cytotoxic than larger ones and 500 nm particles were found to be non-toxic.26 Similarly, a 
different study using mesoporous nano- and micron-sized silica particles showed that 
1220 nm particles were significantly less cytotoxic than 190 and 420 nm particles in both 
human breast cancer cells and African green monkey kidney cells.27  
Numerous reports have suggested that particle diameter is one of the key factors 
contributing to the formation of the protein corona. However, these reports have been 
limited to particles with diameters less than 200 nm.28-30 In this work, we investigate the 
adsorption of proteins on bare, spherical silica particles with a wide range of diameters, 
from 70 to 900 nm. We also compare dense and mesoporous silica particles with similar 
diameters. Previous work done by our group examined the relationship between surface 
modifications on 70 nm mesoporous silica and the identity and composition of the protein 
corona. These experiments will inform future studies on the relationship between protein 
adsorption and cytotoxicity. 
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3.2 Experimental Section 
 
3.2.1 Materials and Methods 
All materials were purchased from Sigma Aldrich and used as received unless 
otherwise noted. Nanoparticle morphology and size were studied by transmission 
electron microscopy (TEM) using a JEOL 1400 microscope operating at 80 kV. Samples 
were dispersed in ethanol, transferred to carbon coated copper grids, and then 
immediately imaged. Nitrogen gas physisorption isotherms were measured in a 
Micromeritics Flowsorb apparatus. Surface area calculations were carried out using the 
BET method, pore size distributions were calculated using to the KJS adjustment of the 
BJH method.31 Particle size and ζ-potential measurements were conducted by dynamic 
light scattering (DLS) in a Malvern Instruments Zetasizer Nano ZS. Dried materials were 
re-suspended in deionized water at a concentration of 5 mg/mL and measurements were 
performed at 25 ˚C. In the case of bigger particles (e.g., particle diameter of about 1 mm), 
sodium silicate 0.15% was added to the medium in order to keep a stable colloid. The 
mean hydrodynamic diameter was determined by cumulant analysis. The organic content 
on the different samples before and after protein adsorption was quantified by 
thermogravimetric analysis in a Mettler-Toledo TGA/SDTA851e apparatus. 
 
3.2.2  Synthesis of Dense 85, 250, and 500 nm Silica Particles.  
The syntheses of these particles were conducted by modifying the Stöber 
method.32 The following procedure describes the synthesis of 85 nm particles; Table 3.1 
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shows adjustments made for the three different particle diameters. EtOH (100 %, 20 mL) 
was mixed with NH4OH (13.7 M, 1.5 mL) in a 100 mL round-bottom flask equipped with 
a magnetic stir bar. This mixture was allowed to thermally equilibrate before 
tetraethoxysilane (TEOS, 2 mL in 5 mL ethanol, 7 mL, 8.96 mmol) was added to the 
solution. This mixture was then stirred for 1 h at room temperature. Afterwards, the 
precipitate was isolated via centrifugation (14,800 rpm, 5 min) and resuspended in 
ethanol using a Branson 2510 sonicator operating at 40 kHz. This process was repeated 
three times in order to remove as much unreacted reagent as possible. Aggregation was 
avoided by suspending the nanoparticles in ethanol and briefly sonicating every few days.  
 
Table 3.1. Conditions used to prepare 85, 250, and 500 nm dense silica particles. 
particle diameter EtOH (mL) 
H2O 
(mL) 
13.7 M NH4OH 
(mL) 
TEOS 
(mL) 
time 
(h) 
85 nm 20.0 -- 1.5 2 + 5 mL EtOH 1 
250 nm 46.0 -- 10 1 + 4 mL EtOH 2 
500 nm 80.0 8.62 5.73 (8.73 M) 5.58 8 
 
 
3.2.3 Synthesis of Dense 900 nm Silica Particles 
Synthesis of these particles was carried out in a two-step process. Seed particles 
were first synthesized using a previously reported procedure.23 Briefly, NH4OH (13.7 M, 
10.0 mL) and EtOH (100%, 50 mL) were combined and allowed to thermally equilibrate. 
TEOS(0.5 mL in 2 mL EtOH, 0.24 mmol) was then added and the mixture was stirred for 
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2 h at r.t. After 2 h, a solution of TEOS (7 mL in 28 mL EtOH, 33.6 mmol) was slowly 
added via a separatory funnel (~0.5 mL/min). Following the final addition of TEOS, the 
particles were stirred for an additional 2 h, and then isolated and washed through 
centrifugation. To remove large aggregates, particles were filtered through a 5 µm filter 
prior to protein adsorption experiments. 
 
3.2.4   Synthesis of 70 nm Mesoporous Silica Particles  
Hexadecyltrimethylammonium bromide (CTAB, 1.00 g, 2.76 mmol) was 
dissolved in a solution of sodium hydroxide (14 mM, 500 mL) at 80 ˚C and stirred 
rapidly. Tetraethyl orthosilicate (TEOS, 5.0 mL, 22.4 mmol) was then slowly added to 
the solution. The composition of the resulting gel was 1 SiO2:0.12 CTAB:0.31 
NaOH:1245 H2O. After 2 h, the resulting mixture was cooled on ice, and the precipitate 
was removed by filtration and washed with water and methanol. The solid was then dried 
at 100 ˚C overnight and calcined at 540 ˚C for 6 h in air.   
 
3.2.5   Synthesis of 850 nm Mesoporous Silica Particles 
  Mesoporous silica particles of 850 nm were synthesized according to a previously 
published protocol.33  EtOH (100%, 138 g), Milli-Q H2O (162 g), and NH4OH (28.95 
wt%, 11.6 mL) were combined in a round bottom flask equippied with a magnetic stir 
bar. CTAB (0.280 g, 0.768 mmol) was then added and allowed to completely dissolve. 
After 5 min, TEOS (1.388 mL, 6.66 mmol) was added and the reaction proceeded for 2 h 
at r.t. The resulting mesoporous silica particles were then isolated via centrifugation, and 
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washed several times with EtOH and H2O. Finally, the particles were dried under vacuum 
for 24 h prior to calcination. Removal of the surfactant was achieved by calcining the 
material at 550 oC for 6 h.   
 
3.2.6   Protein Adsorption Experiments  
Prior to serum exposure, particles were suspended in PBS and diluted to achieve 
a final concentration of 1 mg/50 µL. Subsequently, an aliquot containing 1 mg of 
particles was added to 10 % FBS/DMEM (1 mL). After incubation at room temperature 
for 1 h, the protein-adsorbed particles were isolated through centrifugation and washed 
three times with PBS (1 mL) to ensure that any free or loosely bound proteins were 
removed from the solution. 
 
3.2.7   SDS-PAGE 
One-dimensional sodium dodecyl sulfate-polyacrylamide gel electrophoresis 
(SDS-PAGE) was performed on the proteins isolated after serum incubation. Removal of 
the hard corona was achieved by sonicating nanoparticles in Laemmli buffer (63 mM 
Tris-HCl, pH 6.8, 40 mM DTT, 0.01% (w/v) bromophenol blue, 10% glycerol, 2% (w/v) 
SDS). Particle suspensions were then boiled for 5-10 min in a hot water bath. Particles 
were then removed from the suspension through centrifugation (14,800 rpm, 5 min) and 
the supernatant was saved for SDS-PAGE analysis. Protein separation was then 
performed on a Bio-Rad Mini-PROTEAN electrophoresis system (120 V, 1.5 h). The 
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gels were then stained for 2 h using GelCode blue stain reagent (Thermo Scientific), 
followed by de-staining overnight in deionized water.  
 
3.2.8   Proteomics Analysis 
The digested peptide sample was desalted using a ZipTip C18 (P10, Millipore 
Corporation, Billerica, MA) according the manufacturer’s protocol, and then dried in a 
SpeedVac. The dried peptide samples were dissolved in 20 µl 0.1% formic acid and 2% 
acetonitrile, and 5 µl were loaded onto a fused silica microcapillary LC column (12 cm x 
100 µm inner diameter) packed with C18 reversed-phase resin (5 µm particle size; 20 nm 
pore size; Magic C18AQ, Michrom Bioresources Inc.). Peptides were separated by 
applying a gradient of 3-60% acetonitrile in 0.1% formic acid at a flow rate of 250 
nL/min for 45 min. Nanospray ESI was used to introduce peptides into a liner ion trap 
(LTQ)-Orbitrap mass spectrometer (Thermo Fisher Scientific) via a nanospray ionization 
source. Mass spectrometry data was acquired in a data-dependent acquisition mode, in 
which an Orbitrap survey scan from m/z 400-2000 (resolution: 30,000 FWHM at m/z 
400) was paralleled by 10 LTQ MS/MS scans of the most abundant ions. After an LC-
MS run was completed and spectra were obtained, the spectra were searched against the 
IPI Bovine protein sequence databases (V 3.85) using Proteome Discoverer software 
(version 1.4; Thermo Electron, San Jose, CA). The search parameters permitted a 20 ppm 
precursor MS tolerance and a 1.0 Da MS/MS tolerance. Oxidation of methionine (M) and 
carboxymethylation of cysteines (C) were allowed as variable modifications. Up to two 
missed tryptic cleavages of peptides were considered. The cutoffs for SEQUEST 
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assignments were: cross-correlation (Xcorr) scores greater than 1.9, 2.5, and 3.0 for 
peptide charge states of +1, +2, and +3, respectively; and a delta-correlation (∆Cn) score 
> 0.1. Then, all .srf files for each sample were inputted into Scaffold (version 
Scaffold_4.0.5, Proteome Software Inc., Portland, OR) for the calculations of total 
spectrum counts. 
 
3.2.9   Calculation of Mass Percentage of Individual Proteins. 
Following triplicate analysis of adsorbed proteins by LC-MS, the normalized 
spectral counts (NSpC) for each protein, which represent the percentage of each protein 
identified in the proteomics analysis as a function of molecular weight, were multiplied 
by the overall mass of adsorbed protein as determined by thermogravimetric analysis 
(TGA). The result of this calculation (NSpC × TGA) is the contribution of each protein to 
the total adsorbed mass; standard deviations were determined from these values. 
 
3.3   Results and Discussion 
To investigate the influence of particle diameter on the adsorption of proteins 
from serum, four batches of dense, silica spheres with diameters between 85 and 915 nm 
(as determined by TEM, Table 3.2 and Figure 3.1) were synthesized using 
modifications of the Stöber method. For simplicity, they are called 85, 250, 500, and 900 
nm particles throughout this manuscript.  
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Figure 3.1. Transmission electron microscopy (TEM) images of particles with 
nominal diameters of (a) 85, (b) 250, (c) 500, and (d) 900 nm. Mesoporous 
particles of (e) 70, and (f) 850 nm are also shown. Note the different scale bars in 
each image. 
 
DLS analysis was performed to analyze the ζ-potential, polydispersity index 
(PdI), and hydrodynamic diameter of each particle population (Table 3.2). Because our 
primary interest for this investigation was to survey the identity and composition of the 
protein corona as a function of particle diameter, materials with similar physicochemical 
properties were of great importance for both dense and mesoporous particles. For the 
porous materials, N2 physisorption revealed type IV isotherms for both samples, 
indicative of a mesoporous structure (Figure 3.2).  
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Figure 3.2. Pore size distributions of 70 nm and 850 nm mesoporous silica 
particles.   
 
The surface areas and pore diameters were consistent with expected values for 
mesoporous materials. Particle diameters were reasonably similar between TEM and 
DLS measurements with the exception of sample d; in this case, the large PdI value was 
an indication of the difficulty in obtaining DLS measurements for large dense particles, 
which can be subject to sedimentation within the optical cell in which sampling took 
place. Sample f showed a closer diameter between TEM and DLS measurements, 
although the PdI was larger, consistent with sample d. Plots of particle size distribution 
for all samples may be found in Figure 3.3.  
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Figure 3.3. Particle size distributions of the particles used in these studies. (As 
described in the manuscript, sample names are defined by the diameter measured 
by TEM). 
 
For consistency with the dense particles, porous particle diameters will be represented by 
the approximate TEM diameters (70 and 850 nm). Also of note was the difference in z-
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potential between dense and porous particles. This was most likely due to the calcination 
step used to remove the surfactant from samples e and f after synthesis to open the 
porosity. Calcination led to condensation of surface silanols and reduction of surface 
charge. Although z-potential played a part, protein adsorption appeared to be driven 
primarily by other factors (see below). This is consistent with the results of Mahmoudi et 
al., who demonstrated that other forces, i.e. protein hydrophobicity/hydrophilicity, 
London dispersion, protein-protein interactions, and hydrogen bonding, were the 
predominating factors in driving the formation of the protein corona.15  
 
Table 3.2. Summary of TEM, dynamic light scattering (DLS), and z-potential 
measurements of the particles in Figure 3.1. Measurements of particle diameters 
from TEM represent an average of 50 particles.  
 
 Diameter (nm)   
 sample TEM DLS z-potential (mV) PdI 
 
 
dense 
a 85 ± 9 137 ± 55 - 37.7 ± 5.9 0.123 
b 251 ± 10 281 ± 85 - 22.6 ± 6.0 0.074 
c 482 ± 37 525 ± 201 - 37.2 ± 5.2 0.265 
d 914 ± 21 1496 ± 133 - 20.1 ± 8.6 0.401 
 
porous 
e 73 ± 11 119 ± 60 - 12.2 ± 5.5 0.251 
f 869 ± 45 754 ± 459 - 11.6 ± 4.8 0.371 
 
 
To evaluate the role of particle diameter on the protein corona composition and 
identity, particles of each diameter were incubated in Dulbecco’s Modified Eagle’s 
Medium (DMEM) supplemented with 10% fetal bovine serum (FBS) at a fixed 
 84 
concentration of 1 mg/mL for 1 hour at room temperature. Removal of the soft corona 
was achieved by isolating the particles through centrifugation, followed by repeatedly 
washing the particles with PBS. In order to measure the mass percentage of the remaining 
adsorbed proteins (i.e., the hard corona), the particle-protein complexes were dried under 
vacuum for at least 24 h prior to analysis. Thermogravimetric analysis (TGA) was then 
performed and the total amount of adsorbed protein was calculated as a function of 
weight loss (Table 3.3).  
 
Table 3.3. Summary of protein adsorption data including normalization for 
surface area and surface charge. 
 sample dDLS (nm) 
SABET 
(m2g-1) 
SADLS 
(m2g-1) 
protein 
(mg/100 mg)a 
protein per 
unit SADLS 
(mg/m2) 
ζ-potential per 
unit SADLS 
(- mV/m2g-1) 
dense 
a 137 -- 19.9 10.6 5.33 1.89 
b 281 -- 9.71 7.38 7.61 2.33 
c 525 -- 5.19 4.42 8.52 7.17 
d 1496 -- 1.82 4.18 22.9 11.0 
porous 
e 119 1010 22.9 13.9 6.07 0.533 
f 754 1012 3.61 5.22 14.5 3.21 
 
 
The DLS diameter was used to calculate surface areas of dense particles because 
it was measured in solution. TGA analysis indicated that the smallest particles adsorbed 
the greatest amount of protein. This was due to differences in total surface area. For 
example, at 1 mg/mL, the available surface area for protein adsorption was an order of 
magnitude different between samples a and d. However, normalizing the total amount of 
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adsorbed protein to the total surface area of each sample showed the opposite trend, 
where increasing the particle diameter greatly increased the amount of adsorbed protein. 
It has been hypothesized that the decreased surface curvature of larger particles favors 
protein binding, as proteins are able to pack together more closely on smoother 
surfaces.11,34 Finally, normalizing the z-potential to the total surface area of each sample 
also showed the impact of decreased surface area, with the charge increasing as particle 
diameter increased. 
The identity and composition of the hard corona were analyzed using one-
dimensional sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) 
and electrospray liquid chromatography mass spectrometry (LC-MS/MS). SDS-PAGE 
analysis showed a complex mixture of proteins isolated from the particles (Figure 3.4). 
While the biomolecular fingerprint of the protein corona appeared to be similar for each 
particle diameter, differences in concentrations were apparent.  Quantification of 
individual proteins was performed by combining the thermogravimetric data with the 
spectral counts obtained from LC-MS/MS analysis (Equations 1 & 2, Table 3.4). In 
these equations, SpCk and NSpCk are the spectral counts and normalized spectral counts 
for an individual protein k, taken from LC-MS/MS analysis; Mwk is the molecular weight 
of protein k, and TGA is the weight of protein adsorbed onto the particles in µg/mg 
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Figure 3.4. SDS-PAGE of isolated corona proteins. 
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For all particle diameters and types, proteins with molecular weights below 50 kDa 
comprised the majority of the protein corona, totalling between 60 and 80 % of the total 
mass of adsorbed protein (Figure 3.5). Interestingly, as the particle diameter increased, 
the mass percent of proteins with molecular weights between 50 and 100 kDa also 
increased, at the expense of proteins below 50 kDa. In general we observed the trend that 
larger particles adsorbed a greater fraction of proteins with higher molecular weights. 
While there appears to be an exception for the 900 nm dense particles, which adsorbed 
more proteins in the 50 – 100 kDa range but fewer proteins above 100 kDa, the total mass 
of protein adsorbed for this sample was small compared to the other particles. 
Consistent with our previous data and many other results in the literature,16,35 the 
amount of the proteins in the corona did not correlate with their relative abundance in the 
serum.36  For example, serum digestion and analysis confirmed that serum albumin was 
one of the most abundant proteins found in the 10% FBS used for these experiments (data 
not shown), but it was found in relatively low abundance on all samples that were 
analyzed, comprising less than 4% of the complete corona in each class of particles. 
Similarly, one of the most abundant serum proteins, serotransferrin, was also not 
identified on any particle sample. On the other hand, apolipoprotein A-II, a light protein 
(~11 kDa) found in high concentrations in serum, was the most abundant protein (14 %) 
of the corona for 85 nm particles and was a major component of the corona of all 
particles. Here, the higher surface curvature of small nanoparticles favored the 
enrichment of smaller proteins;37,38 particles of 250, 500 and 900 nm were better able to 
accommodate heavier proteins such as apolipoprotein E (~30 kDa).  
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Figure 3.5. Comparison of the weight percent of the protein corona (NSpC × 
TGA) across dense and porous particles with different diameters, with respect to 
(left panel) molecular weight; (right panel) isoelectric point.  
 
We36 and others27,39,40 have previously shown that the z-potential of the particles 
becomes less negative upon protein adsorption. Regardless of ζ-potential, none of the 
particles exhibited a preference for protein adsorption based on the protein’s isoelectric 
point (Figure 3.5). This is rather surprising given the negative z-potentials present on 
each type of particle. Based on electrostatic interactions, one could hypothesize that 
particles possessing a negative surface charge would preferentially bind positively-
charged proteins. However, others have suggested that neither protein size nor charge 
significantly determine the protein fingerprints, confirming that electrostatic affinity 
alone does not constitute the major driving force regulating the silica-corona 
interactions.41  
Protein adsorption onto porous silica particles is a more complicated process than 
for dense silica particles. The addition of pores along the particle surface provides 
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openings, or void spaces, into which proteins may diffuse. Indeed, numerous 
investigations have reported on the immobilization of proteins within mesoporous 
materials.42-44  However, diffusion deep into mesoporous materials with pore diameters 
on the order of 4 nm (as used here) in the presence of complex protein mixtures is slow 
even for low molecular weight proteins, because the diameters of the folded proteins are 
similar to the pore diameter. Therefore, proteins are likely to gather at the pore entrances 
and prevent adsorption throughout the interior of large particles, so that much of the 
internal surface area becomes inaccessible after the first proteins are adsorbed.45,46 Some 
confirmation of this idea is provided by the fact that although the total surface area of the 
porous particles was much larger than the dense particles, the total amount of protein 
adsorbed (Table 3.3) and the trends in specific adsorption between the two groups are not 
very different. Also consistent with dense particles was the fact that, comparing groups of 
porous particles, the amount of low molecular weight proteins decreased as particle 
diameter increased. 
On the other hand, when comparing porous particles to dense particles of the 
same or similar diameters, some differences become apparent. Most notable is that the 
fraction of low molecular weight proteins in the corona is even more enhanced when the 
particles are porous, regardless of particle diameter. This is particularly obvious when 
comparing smaller porous and dense particles; at least 80% of the proteins in the corona 
of the 70 nm porous silica particles had molecular weights less than 50 kDa (Figures 3.5 
and 3.6). Thus in addition to the influence of surface curvature, a size exclusion effect 
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related to the small pore diameter (~ 4 nm) also enhanced the adsorption of smaller 
proteins. This is consistent with our previous protein adsorption study.38 
 
Figure 3.6. Heat map illustrating the differences in protein corona composition of 
porous and dense silica particles. Only proteins with concentrations greater than 
1.5 µg/mg particles are included. Note that the color gradients are nonlinear to 
facilitate observation of proteins present in small amounts.  
 
Finally, it is interesting to note the biological function of proteins present in the 
corona. Consistent with other literature results, apolipoproteins comprised a majority of 
the protein corona on all dense and porous samples.47 Tenzer and coworkers 
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demonstrated that these lipoproteins, which are actively involved in lipid and cholesterol 
transport, promote nanoparticle internalization in endothelial cells. However, in the 
absence of additional in vitro studies, assessing the impact of having this class of proteins 
in the corona is speculative. We are currently performing in vitro and in vivo studies to 
address issues related to particle-cell interactions. 
 
3.4   Conclusions 
Monodisperse dense and mesoporous silica particles were synthesized with a 
range of diameters from 70 – 900 nm in order to study the relationship between particle 
diameter and the formation of the protein corona. Small particles adsorbed the largest 
amount of protein, regardless of whether they were dense or porous. For dense particles, 
this was due in part to the larger surface area of the particles. Although the porous 
particles had nearly identical surface areas due to their large internal porosity, and 
therefore one might expect them to adsorb similar amounts of protein, the larger porous 
particles unexpectedly adsorbed significantly less protein than the smaller porous 
particles. This is attributed to pore blockages created by early-adsorbing proteins, which 
limit the surface area available to the external particle surfaces. Small dense particles 
adsorbed lower molecular weight proteins, due to their large surface curvature. 
Interestingly, porous particles of any diameter adsorbed a much greater fraction of low 
molecular weight proteins, due to the size exclusion effect related to pore diameter. 
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CHAPTER 4. SPATIAL MODELING OF PROTEIN ADSORPTION ON 
MESOPOROUS SILICA NANOPARTICLES BY STOCHASTIC OPTICAL 
RECONSTRUCTION MICROSCOPY (STORM) 
 
4.1   Introduction 
Exposure to biological fluid envelops nanoparticles in layers of proteins and 
biomolecules, which has a profound impact on the nanoparticle's biological fate. 
Although the identities and amounts of the proteins in this "corona" have been thoroughly 
examined, the spatial arrangement of the proteins is unclear, a problem that is 
compounded on porous nanoparticles due to penetration of proteins within the porous 
network. To address this problem, we have developed a procedure based on information 
derived from stochastic optical reconstruction microscopy (STORM). We employed a 
mathematical model to reveal the penetration depth of several proteins within porous 
nanoparticles. Understanding protein penetration depth provides an explanation for the 
composition of the protein corona, aiding in the development of safe and effective 
particle-based therapies. 
The formation of the protein corona, that is, the layer of proteins that resides on 
a material after exposure to biological fluid, has been well documented in recent 
years.1,2,3,4 Dawson and coworkers5 have studied the complex nature of this process on a 
wide variety of materials, including silica and polystyrene particles. Particle diameter,6 
surface charge,7 surface chemistry,8 and surface area9 have all been shown to influence 
the formation and composition of the protein corona. Once adsorbed, the protein corona 
has been shown to affect particle-cell interactions,10,11,12 inhibit the ability of 
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nanoparticles to target specific cell types,13 influence nanoparticle pathophysiology1, and 
mitigate cytotoxicity.14 While many studies have involved the identification and 
quantification of the protein corona, very few have investigated the spatial mapping and 
orientations of the adsorbed proteins,15,16 and of those studies, only dense materials have 
been used, imposing limits on our understanding of how porous materials interact with 
biological environments. 
We have recently published studies on the composition of the protein corona 
adsorbed onto mesoporous silica nanoparticles (MSNs).6,17 One striking feature of the 
corona, particularly on nanoparticles with small diameters (< 100 nm), was the 
preferential adsorption of low molecular weight (MW) proteins. We hypothesized that 
one reason for this enhancement was the diameter of the nanoparticle's pores, which 
prevented larger, higher MW proteins from accessing the porous network on the interior 
of the nanoparticles. This led to a search for an experimental technique that could be used 
to study the penetration depth of fluorescently labeled proteins within MSNs. Recent 
advancements in single molecule fluorescence microscopy have unveiled new 
opportunities to understand the complex behavior of biological systems. Whereas other 
wide-field fluorescence microscopy methods, such as confocal fluorescence microscopy, 
have diffraction limits of 250 nm (Figure 4.1), STORM exploits the inherent nature of 
photoswitchable fluorophores to generate an image of high-resolution.18 Under 
appropriate optical and chemical conditions, photoswitchable fluorophores will 
stochastically turn on/off, allowing the instrument to record these blinks through many 
frames. As this process is repeated through numerous cycles, the fluorophores can be 
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mapped with high localization accuracy.19 Numerous groups have reported an order of 
magnitude increase in resolution.20,21,22 Deconvolution procedures to manipulate wide-
field fluorescence microscopy images after acquisition only improve upon the images 
slightly (Figures 4.1c and 4.1d). While STORM has been successfully used in a number 
of biological applications,21,23 it is also an ideal tool for experiments at the topical 
intersection of biology and materials science. 
 
Figure 4.1. Comparison of microscopic imaging of protein adsorption on MSNs. 
Albumin was fluorescently labeled with Alexa Fluor 647 and used for analysis. 
(a) and (e), STORM image of nanoparticles following protein adsorption. (b) 
TEM image of as-prepared particles. (c) Wide-field fluorescence image from 
confocal fluorescence microscopy. (d) Deconvolved wide-field fluorescence 
image. Scale bars, 1000 nm.  
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4.2   Experimental Section 
 
4.2.1   Materials and Methods 
 All chemicals were purchased from Sigma Aldrich unless otherwise noted. Alexa 
Fluor 647 was purchased from Thermo Scientific and used according to the 
manufacturer’s protocol. All proteins were purchased from Athen Research & 
Technologies.  
 
4.2.2   Nanoparticles  
Mesoporous silica nanoparticles of 830 nm were synthesized according to a 
previously published protocol. Following the synthesis, the template was removed by 
heating the material at 550 ˚C for 6 h to afford the small pore material. A portion of this 
material was then suspended in 1M NH4OH, placed in a Teflon bottle, and heated at 100 
˚C for 30 min to afford the large pore material.  
 
4.2.3   Synthesis of 830 nm Mesoporous Silica 
Mesoporous silica of 830 nm was synthesized according to a previously 
published protocol.24 Ethanol (100 %, 138 g, mol) was combined with Milli-Q water (162 
g, mol) in an Erlenmeyer flask equipped with a magnetic stir bar. Ammonium hydroxide 
(28.95 wt %, 11.6 mL) was then added and the solution was briefly mixed. 
Cetyltrimethylammonium bromide (CTAB, 0.280 g, mol) was then added and stirred 
until all of the CTAB had dissolved. After 5 min., tetraethylorthosilicate (TEOS, 1.388 
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mL, mol) was added and the reaction proceeded at r.t. for 2 h. Following, the material 
was isolated via centrifugation (15,000 g, 10 min). The material was then thoroughly 
washed with a mixture of water and ethanol before drying under vacuum for 24 h. 
Removal of the surfactant was achieved by calcining the material at 550 oC for 6 h.  
 
4.2.4   Synthesis of Large Pore Mesoporous Silica 
Pore-expansion of the parent material was carried out according to a previously 
published protocol.25 The calcined, small pore material was suspended in ammonium 
hydroxide (1 M, 40 mg particles/mL) in a Telfon bottle and briefly sonicate using a 
Branson 2510 sonicator operating at 40 kHz. The Telfon-sealed bottle was then placed in 
a 100oC and the reaction was allowed to proceed for 30 min. After removing from the 
oven, the material was isolated via centrifugation and repeatedly washed with ethanol 
before drying under vacuum for 24 h.  
 
4.2.5   Protein Labeling & Adsorption  
NHS-modified Alexa-Fluor 647 was conjugated to the selected proteins 
following a procedure published by Molecular Probes. Separation of free dye from 
protein was then performed using a Sephadex G-25M column. To concentrate the protein, 
the fluorophore-modified protein was repeatedly centrifuged and washed through 
nanostep centrifugation filters (MW cutoff > 4 kDa).  Protein concentrations were then 
determined by BCA. For all protein adsorption experiments, the concentration of 
particles to protein was held constant at 1 mg/100 µg. Particles suspended in PBS (10 
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mM, pH 7.4, 1 mg/50 µL) were briefly sonicated prior to each experiment (Branson 2510 
at 40 kHz, 5 min). To an eppendorf containing fluorophore-modified protein (100 µg in 1 
mL PBS), an aliquot containing 1 mg of particles (50 µL) was added and incubated on a 
shaker for 1 h at r.t. Subsequently, the particles were isolated via centrifugation (10,000 
rpm, 1 min) and then resuspended in PBS (1 mL). This process was repeated three times 
in order to remove any loosely bound protein.  
 
4.2.6   Protein Labeling & Adsorption for Binary Mixtures  
For binary adsorption and imaging, Alexa-Fluor 647 was conjugated to both 
albumin and complement C3c following the previously outlined procedure. 
Apolipoprotein A-II was modified with Alexa-Fluor 568 following the same procedure. 
For all binary adsorption experiments, the total concentration of protein remained at 100 
µg/mg particles (50 µg protein A, 50 µg protein B). To an eppendorf containing the 
protein mixture (100 µg/mL PBS), an aliquot containing 1 mg of particles (50 µL) was 
added and incubated on a shaker for 1 h at r.t. The particle-protein complexes were then 
isolated via centrifugation (10,000 rpm, 1 min) and resuspended in PBS (1 mL). This 
process was repeated three times in order to remove any loosely bound protein.  
 
4.2.7   STORM Imaging  
Prior to all imaging experiments, MatTek glass slides were cleaned according a 
previously published protocol.26 Following, protein-adsorbed samples were resuspended 
in PBS (100 µL) and aspirated onto the glass slide. Imaging buffer was then added and 
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the protein-adsorbed particles were immediately imaged on a Nikon Eclipse Ti-E 
microscope. A minimum of 20,000 frames was collected for STORM analysis. All 
molecules exhibiting a peak height > 300 (background) were considered for analysis. For 
the binary mixtures, each fluorophore was collected in independent acquisitions. First 
568-labeled apolipoprotein A-II, immediately followed by 647-labeled albumin or 
complement C3c. For both fluorophores, a minimum of 10,000 frames was collected and 
all molecules exhibiting a peak height > 500 were considered for analysis.  
 
4.2.8   Three-Dimensional Reconstruction  
Following image acquisition, individual particles were selected using the ROI 
feature in NIS-Elements. The molecules associated within the selected ROI were then 
used to construct the spherical model. Using the molecular coordinates, a least squares 
sphere-fitting algorithm was applied using a custom program written in Python. Once the 
center of the sphere and radius had been calculated, these values, in addition to the 
protein coordinates, were used to reconstruct a 3D model in Blender. A detailed 
description of this calculation can be found in the Section 4.2.11.1. 
 
4.2.9   Characterization of Nanoparticles 
Nanoparticle morphology and size were studied by transmission electron 
microscopy (TEM) using a JEOL 1400 microscope operating at 80 kV. Samples were 
dispersed in ethanol, transferred to carbon-coated copper grids, and then immediately 
imaged. Nitrogen gas physisorption isotherms were measured in a Micromeritics 
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Flowsorb apparatus. Surface area calculations were carried out using the BET method, 
pore size distributions were calculated using to the KJS adjustment of the BJH method27 
 
Figure 4.2. TEM micrographs of small (a) and large (b) pore mesoporous silica. 
Scale bar : 500 nm 
 
 
Figure 4.3. N2 physisorption isotherms and pore distributions of small and large 
pore mesoporous silica  
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4.2.10   Protein Labeling and Quantification  
Proteins were used as received from Athens Research and Technologies. Proteins 
were reconstituted in PBS (10 mM, pH 7.4) at a concentration of 1 mg/mL. An aliquot 
containing 200 µg of protein was then transferred to a new eppendorf and NHS-
terminated Alexa Fluor 647 (20 µg, 10 mg/mL DMSO) was added to this solution. The 
reaction was allowed to proceed in the dark for 2 h at r.t. Separation of 647-conjugated 
protein and free dye was performed using a Sephadex G-25 column (eluent: 10 mM PBS, 
pH 7.4). Protein solutions were then concentrated using nanostep centrifugation filters 
(MW cutoff > 4 kDa). Finally, protein concentrations were determined using the Pierce 
BCA Protein Assay Kit.  
 
4.2.10.1   Protein Adsorption 
Calcined particles were suspended in PBS (10 mM, pH 7.4) at a concentration of 
1 mg/50 µL. The particle suspension was then sonicated to disperse any aggregates. An 
aliquot containing 1 mg of particles was then transferred to a new eppendorf and diluted 
to a final concentration of (1 mg/0.5 mL) with PBS containing 647-labeled protein (100 
µg protein). The adsorption proceeded for 1 h before isolating the particle-protein 
complexes via centrifugation (1 min, 14,800 rpm). The protein-adsorbed samples were 
then resuspended in PBS (1 mL), sonicated, and centrifuged. This process was repeated 
three times in order to remove any loosely bound protein.  
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4.2.10.2   Slides and Buffer Preparation  
In order to reduce non-specific adsorption of 647-labeled protein, all imaging 
slides were thoroughly cleaned in potassium hydroxide (1 M) and piranha solution (3:1, 
H2SO4: H2O2) following to a previously published protocol.26 Imaging buffer was 
prepared fresh before each experiment and was prepared according to a previously 
published recipe. 
 
4.2.10.3   Particle-Protein Imaging 
After preparing the glass slides and buffer, protein-adsorbed particles were 
suspended in 100 µL of PBS. After sonicating the sample, the sample was aspirated onto 
the glass imaging slide. After allowing the particles to settle on the glass slide (2-3 min) 
the excess PBS was removed. Imaging buffer (1.5 mL) was then very slowly added to the 
dish and the sample was immediately imaged on a Nikon Eclipse Ti-E microscope. The 
composition of the buffer used for these experiments consisted of Tris buffer (1 mL, 50 
mM Tris-HCl (pH 8.0), 10 mM NaCl, 10% glucose), an oxygen scavenging system 
(0.5mg mL-1 glucose oxidase, 40 µg mL-1 catalase), and 2-mercaptoethanol (MEA, final 
concentration 100 mM). Fresh imaging buffer was prepared prior to each experiment. For 
all samples, a minimum of 20,000 frames was collected to generate the final STORM 
image. A minimum peak height value of 300 was used for all samples.  
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4.2.11   Sphere Fitting and Analysis  
Following image acquisition, individual spheres were selected and all data associated 
within that region of interest (ROI) was exported for analysis. Within a selected ROI, the 
Cartesian coordinates associated with each localization were used to model the sphere of 
best fit. Performing this calculation provides both the center of the sphere (xc, yc, zc) and 
the radius of the calculated sphere, rc.  
 
4.2.11.1   Sphere Fitting 
The sphere of best fit was found by minimizing the function:28 
 J =  ((x! − x!)!!!!! + (y!  −  y!)! + (z! −  z!)! −  r!!)!  (4.1) 
I = number of data points 
(xi, yi, zi) = ith measurement of the origin 
(xc, yc, zc) = center of sphere 
rc = radius of sphere 
𝑥!𝑦!𝑧! =  12
𝑥!! (𝑥! − 𝑥) 𝑥!! (𝑦! − 𝑦) 𝑥!! (𝑧! − 𝑧)𝑦!! (𝑥! − 𝑥) 𝑦!! (𝑦! − 𝑦) 𝑦!! (𝑧! − 𝑧)𝑧!! (𝑥! − 𝑥) 𝑧!! (𝑦! − 𝑦) 𝑧!! (𝑧! − 𝑧)
!! (x!!! + y!! + z!!)(x! − x)(x!!! + y!! + z!!)(y! − y)(x!!! + y!! + z!!)(z! − z)
 
 
r! =  1I ((x! − x!)!!!!! + (y!  −  y!)! + (z! −  z!)!) 
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4.2.11.2   Distance Calculations 
Once the center of the sphere had been determined (xc, yc, zc), the distance from each data 
point to the center was determined according to the following calculation: 
 d = x! −  x! ! + y! −  y! ! + z! −  z! ! (4.2) 
 
d = distance from origin to data point (nm) 
(xi, yi, zi) = x, y, z coordinates of individual data point 
(xc, yc, zc) = center of sphere 
 
4.3   Results and Discussion 
The calculations described below rely on a spherical nanoparticle model; thus, 
careful preparation of a highly monodisperse MSN population was important. While it is 
possible to prepare monodisperse MSNs with a variety of diameters, we chose a 
relatively large diameter for these experiments because it allowed the best discrimination 
in penetration depth among the three proteins. Highly monodisperse, spherical MSNs 
with a diameter of 830 nm as determined by transmission electron microscopy (TEM) 
were prepared using a previously published procedure.24 Analysis of the porosity of these 
particles by N2 physisorption showed a surface area of 837 m2g-1, pore volume of 0.54 
cm3g-1, and pore diameter of 3 nm (Figures 4.2 and 4.3). These MSNs are referred to as 
"small pore" in these experiments. Exposure of this material to 1.0 M NH4OH for 30 min 
(see Experimental Procedures) caused etching of the pores, leading to a material with a 
smaller surface area and pore volume but larger pores (304 m2g-1, 0.38 cm3g-1, and 6 nm, 
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respectively). These MSNs are referred to as "large pore" and had a diameter of 913 nm 
from TEM. Although it is possible to directly prepare MSNs with larger pores that would 
have a more narrow pore size distribution, it was important to have small and large pore 
materials with very similar particle diameters for comparative measurements of 
penetration depth within the MSNs. To investigate the relationship between pore 
diameter and protein adsorption, we selected three proteins with different MW: 
apolipoprotein A-II (17 kDa), albumin (66 kDa), and complement C3c (138 kDa), based 
on our previous experiments.6 These proteins are commonly identified in the coronas of 
many types of nanoparticles.29  
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Figure 4.4. Protein adsorption on small and large pore mesoporous silica. 
Adsorption of apolipoprotein A-II (a,d) , albumin (b,e), and complement C3c (c,f) 
on small pore (a,b,c) and large pore (d,e,f) mesoporous silica particles. Scale bars, 
1000 nm 
 
As observed in Figure 4.4, the layer of fluorescently labeled proteins 
surrounding the silica nanoparticles is readily observed by STORM. In these images, 
each spot represents one fluorophore. However, applying this information to the question 
of penetration depth is challenging, because the MSNs do not all lie at the same depth 
within the focal plane of the microscope. For example, if the focal plane lies below or 
above the center of a nanoparticle, the diameter of the nanoparticle would appear smaller 
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than if the focal plane was perfectly in line with its center. This, in concert with the radius 
of curvature, would overestimate the protein penetration depth. Also, assuming the mean 
of all x, y, and z (Cartesian) coordinates of the fluorophores to be the center of the MSN 
is inaccurate due to the asymmetric distribution of proteins on the nanoparticle. To 
address these issues, individual particles were selected for analysis and all molecules 
associated with their respective particles were extracted as Cartesian coordinates. This is 
possible because the STORM data set provides Cartesian coordinates and intensities for 
each fluorophore. For a given particle, protein coordinates were used to calculate the 
sphere of best fit, by minimizing the function previously described (Equation 4.1).28 
An example of the processing method is shown in Figures 4.5a and 4.5b for 
apolipoprotein A-II adsorbed onto small pore MSN. Once the sphere of best fit was 
calculated (Figure 4.5a), all data points associated within 100 nm of the centre (along the 
z-axis) were plotted and the opacity was scaled according to each molecule’s intensity 
(Figure 4.5b).  
This method was employed to analyze the adsorption of apolipoprotein A-II, 
albumin, and complement C3c on small pore and large pore MSNs. To illustrate the 
robustness of this method, three particles were selected from each set of STORM data, 
and the sphere of best fit was calculated (Figure 4.5c). As shown in the figure, 
apolipoprotein A-II and albumin adsorbed in much higher concentrations on both the 
small pore and large pore MSNs as compared to complement C3c. It should also be noted 
that the differences in particle radii across the same material are a function of the 
calculation, in which the calculated radius for any given particle is compressed as higher 
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concentrations of protein are internalized within the nanoparticle. This is particularly 
apparent for the apolipoprotein A-II spheres of best fit. Conversely, protein that 
exclusively localizes on the surface will result in a calculated radius that is larger than the 
true radius. For this reason, all calculated particle radii were normalized to their 
respective TEM values. To compare results within a protein-adsorbed sample, all 
calculated radii were normalized to their respective TEM radius, 415.7 nm for small pore 
and 456.5 nm for large pore.  
To highlight the depth by which a protein may penetrate the particle, a flattened 
z-stack (0 ± 100 nm) of each selected particle was plotted in Figure 4.5d. In the case of 
apolipoprotein A-II, penetration throughout the entire particle is observed for the large 
pore material. Conversely, for the small pore material, a clear void near center of the 
particle indicates the protein is unable to fully diffuse through the particle. Surprisingly, 
in the case of albumin, localized concentrations of protein are observed around the 
particle surface for both materials, suggesting that upon adsorption, albumin clogs the 
pores and inhibits further penetration of the porous scaffold. Finally, only low 
concentrations of complement C3c were observed in all samples. Given the MW of 
complement C3c, it is likely that the protein is unable to penetrate into the pores of either 
material, but instead localizes at the nanoparticle surface. These results are consistent 
with our previous research.6 
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Figure 4.5. Sphere fitting model and analysis on selected spheres. (a) Following 
acquisition of STORM data, a least squares sphere fitting algorithm was applied 
to all data points associated with a selected particle, and the sphere of best fit was 
determined. Once the particle origin was calculated, all molecules within 100 nm 
of the particle center (along the z-axis) were extracted from the data set. (b) To 
highlight the depth by which a particular protein penetrated into the MSN, the 
data points were flattened and plotted as a function of their fluorescence intensity. 
(c, d) This method was employed on both small pore and large pore mesoporous 
silica for each protein. 
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The distance from the calculated nanoparticle origin to each protein was 
calculated using the Pythagorean theorem. Comparison among the protein/MSN pairs 
was evaluated by normalizing all calculated distances to their respective TEM values. 
Once all distances had been calculated, histograms were plotted and Gaussian fits were 
applied for both a single sphere (Figure 4.6a) and average distances for 10 particles 
(Figure 4.6b). In a hollow sphere, protein concentrations would scale by r2, as the radius 
of the particle decreases or increases (Figure 4.6a, dashed line). This theoretical model 
exhibits a broad distribution, with a standard deviation of 137 ± 8.1 nm.    
 
Figure 4.6. Distribution of distances on selected and averaged spheres. 
Distribution of distances on the specific particles shown in Figure 4.2: (a) small 
pore; (c) large pore. The dashed line represents theoretical distribution in a hollow 
sphere. (b, d) Distribution of distances averaged over 10 particles.  
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For proteins that are capable of penetrating close to the particle center, a broad 
distribution similar to that of the theoretical model should be obtained. While 
apolipoprotein A-II showed this distribution for both MSNs, the larger standard deviation 
for the distribution in the large pore MSN, 145 ± 3.2 nm vs. 85.4 ± 1.2 nm, indicated that 
this protein was able to penetrate more deeply into the large pore MSN. This can also be 
qualitatively observed in Figure 4.5d. In addition, when the data over 10 particles is 
averaged (Figure 4.6b), the distribution for apolipoprotein A-II shifted away from the 
normalized particle surface distance. Significantly more of the protein population is 
found inside large pore MSNs as compared to small pore MSNs. This is because the low 
MW of apolipoprotein A-II allows it to fit more easily into the porous network. 
Conversely, a narrow distribution would be expected for proteins that localize at 
or near the surface of the particle; this is observed for both albumin and complement C3c. 
While the albumin and complement C3c distributions are similar in both MSNs, it should 
be noted that the number of albumin molecules identified during analysis was nearly five 
times that of complement C3c. Thus, there is more error associated with the complement 
C3c distribution than the albumin distribution, and the plot cannot take the protein 
clustering observed for the complement C3c data into account. As expected for larger 
proteins, albumin and complement C3c do not show significant shifts in distribution 
between the small and large pore MSNs. 
The maximum penetration depth across each protein/MSN pair was calculated 
by arranging the distances from the center of the MSN to each adsorbed protein in 
ascending order, and then isolating the smallest 5.0% of this population. From this 5.0% 
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subset, a two-sided Grubbs’ Test was applied to remove outliers (based on α = 0.05)30. 
Penetration depth was then calculated by taking the difference between these distances 
and the respective TEM radius. Once this process had been applied across all 10 particles, 
the maximum penetration depth was defined as the average of the largest penetration 
depth for each particle (Figure 4.7). 
 
Figure 4.7. Maximum protein penetration depths. After removing outliers, the 
maximum penetration depth was calculated by averaging the greatest distance for 
each of the 10 particles. Maximum penetration depth for a protein-adsorbed 
sample was determined by first, removing the outliers, and then averaging the 
greatest distance for each particle.  
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  Apolipoprotein A-II penetrated on average nearly 75 nm deeper into the large 
pore MSN compared to the small pore MSN (395 ± 24.1 nm versus 318 ± 27.5 nm). In 
MSNs with a diameter from TEM of 913 nm, this corresponds to nearly complete 
adsorption within the porous network of the MSN (radius = 456.5 nm); in MSNs with 
large pores but smaller diameters, it is likely that this protein would completely penetrate 
through the interior of the MSN. This could have important implications for biological 
applications. Albumin penetration was similar for both the large pore and small pore 
MSN (290 ± 18.9 nm versus 280 ± 29.6 nm) supporting the idea that the increase in pore 
diameter had less of an impact on a protein with a larger MW. Conversely, complement 
C3c penetrated more deeply into the large pore MSN (285 ± 57.5 nm versus 202 ± 58.0 
nm). It should be noted, however, that the number of identified complement C3c 
molecules was far below that of apolipoprotein A-II and albumin for both materials. 
Interestingly, similar penetration depths for albumin and complement C3c for the large 
pore MSN suggests that pore diameters >60 Å are large enough to accommodate both 
proteins, but it is likely that the initially adsorbed protein begins to clog the pores, 
inhibiting further diffusion. This "bottle-necking" effect is most severe for complement 
C3c in small pore MSNs but is reduced in large pore MSNs, hence the large change in 
penetration depth. Because the effect is less severe for albumin in small pore MSNs, so 
the change in penetration depth is not as large. A final compounding factor for 
complement C3c is that there is much less overall protein adsorbed and this protein 
tended to cluster on the MSN surface, while albumin was more evenly distributed within 
and across the surface of the particles (Figure 4.5d). 
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In addition to single protein adsorption experiments, binary mixtures were 
investigated in order elucidate the influence of higher molecular weight proteins on the 
adsorption of apolipoprotein A-II. Surprisingly, penetration depths were similar for both 
small pore and large pore MSNs, suggesting a competitive adsorption model in a binary 
system. Where homogenous adsorption is observed in the case of a single protein system, 
binary mixtures exhibit competitive adsorption for both the internal and external surface 
of the particle. Albumin adsorption demonstrated penetration throughout the porous 
framework for both small pore and large pore MSNs as a single protein solution (Figure 
4.5). However, when administered in concert with apolipoprotein A-II, albumin exhibits 
a much lower adsorption profile, in both quantity and localization. As shown in Figure 
4.8, of those albumin and complement C3c molecules that were identified, the vast 
majority resides at or near the surface of the particle, where penetration throughout the 
particle by apolipoprotein A-II is clearly observed. This finding suggests that in the case 
of a binary mixture, apolipoprotein A-II adsorbs into the pores first, obstructing the 
internal adsorption of albumin and complement C3c. Additionally, the number of 
identified albumin and complement C3c molecules was far less than for the single protein 
experiments.  
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Figure 4.8. Binary adsorption on small and large pore MSNs. Following sphere 
selection, all molecules within 100 nm (along the z-axis) of the center of the 
sphere were flattened and plotted as function of their fluorescence intensity. The 
left column identifies the adsorption of apolipoprotein A-II and the binary 
mixtures on small pore MSNs. The spheres in the right column show the 
adsorption of apolipoprotein A-II and the binary mixtures on large pore MSNs.  
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To investigate if this behavior was conserved in a complex protein mixture, 
protein adsorption from 10% human serum supplemented with fluorescently-labeled 
protein was also analyzed. Interestingly, detection of the labeled protein was only 
observed in the case of apolipoprotein A-II. For both albumin and complement C3c, no 
signal could be observed by fluorescence microscopy, indicating that for both proteins, 
concentrations were too low. Based on previously published research, the protein corona 
on these materials is largely composed of low molecular weight proteins, with 
apolipoprotein A-II comprising nearly 10% of the total corona in some cases (ref). On the 
other hand, albumin and complement C3c, while also found in the protein corona, reside 
in much lower concentrations. Thus, even under forced conditions, adsorption remains 
extremely low due to the propensity of lower molecular weight proteins to dwarf the 
adsorption of higher molecular weight proteins.  
 
4.4   Conclusions 
In summary, we have used STORM to develop a quantitative method to study the 
penetration of proteins within porous silica nanoparticles. This method allowed us to 
differentiate between the adsorption patterns of low, medium, and high MW proteins 
within MSNs that had different pore diameters. The model presented here describes a 
noninvasive technique for both imaging and analyzing protein and molecular adsorption 
in a porous material. It is important to mention that studying the adsorption of individual 
proteins is idealized, compared to protein adsorption from complex mixtures. For 
example, the proteins present in the complete corona interact with each other in a way 
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that will influence their penetration depth. We are currently completing this study and 
will apply the model presented here to these experiments. This model will also be 
extended to investigate the time-resolved dynamics and development of the protein 
corona on porous materials. 
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CHAPTER 5: CONCLUSIONS 
 
Evidenced by the work contained herein, protein adsorption, and specifically the 
formation of the protein corona, is incredibly complex. The goal of this work was to 
deepen our understanding of how the physicochemical properties of dense and 
mesoporous silica nanoparticles influence this process. This was accomplished by 
systematically investigating how changes in surface chemistry, particle size, and porosity 
govern this phenomenon.  
 Initial studies investigating the influence of surface chemistry were performed on 
50 nm MSNs. The parent material baring surface hydroxyl groups was then used to 
produce materials exhibiting different surface functionalities, -NH2, -COOH, -PEG3, and 
-PEG24.  Dynamic light scattering measurements revealed a range of zeta-potentials for 
the different materials. Following protein adsorption, the protein coronas were removed 
and analyzed by gel electrophoresis, shotgun proteomics, and thermogravimetric analysis. 
The electrophoretic patterns demonstrated that the bare, amine, and carboxylated 
materials all exhibited unique protein fingerprints. However, both the PEG3 and PEG24 
modified MSNs showed virtually no indications of protein binding, which was to be 
expected given previous literature results. While apolipoproteins were found in relatively 
high abundance on -NH2, -COOH, and bare materials, proteomics results indicated 
unique protein patterns for each sample. Interestingly, bare and -COOH materials shared 
commonality in both protein concentration and composition.  
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 To explore how particle diameter influenced the composition and identity of the 
protein corona, dense silica particles ranging from 85 – 915 nm were synthesized. As a 
comparison, porous particles of 70 and 900 nm were synthesized as well. It should be 
noted that all materials exhibited excellent monodispersity. Thus, adsorption patterns and 
concentrations should be attributed solely to changes in particle diameter, and not a 
function of aggregation. Following serum exposure, smaller diameter materials presented 
the highest mass of adsorbed protein. This may be attributed to the larger radius of 
curvature and thus higher surface area per gram for the dense material. However, both 
porous materials were nearly identical in surface area per gram, indicating that pore 
blockage on the 900 nm particles inhibited higher adsorption concentrations. Interestingly 
though, proteomic identification demonstrated that all of the materials, regardless of size, 
preferentially adsorbed low molecular weight proteins. This is surprising given the low 
concentrations of these proteins in serum.  
 To further understand this preferential adsorption of low molecular proteins, 
mesoporous particles, ca. 900 nm, were synthesized. Nitrogen physisorption revealed that 
the as-prepared material possessed pore diameters around 3 nm, a typical result for these 
synthetic conditions. A portion of this parent material was then subjected to pore-
expansion conditions, producing particles that were nearly identical in diameter but 
exhibited pore diameters > 6 nm. Three proteins that were commonly identified in the 
protein corona were then chosen for adsorption studies: apolipoprotein A-II (17 kDa), 
human serum albumin (66 kDa), and complement C3c (138 kDa). These model proteins 
were then fluorescently labelled and adsorbed onto the small and large pore particles. To 
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observe protein diffusion/adsorption, stochastic optical reconstruction microscopy was 
used to generate super resolution three-dimensional images. Extracting the cartesian 
coordinates for the identified proteins provided the necessary data to employ a least-
squares sphere-fitting algorithm written in Python, the result of which identifies the 
centre of the sphere in addition to the radius (Figure 5.1).  
 
 
Figure 5.1. Reconstructed particle (wire frame) based on the three-dimensional 
coordinates obtained from STORM analysis. Each blue sphere represents an 
identified localization.  
 
Once the true centre of the particle had been determined, the distance from the surface to 
each identified protein was calculated using Pythagorean theorem. Iterating this 
mathematical process over many particles allowed for statistical averages to be calculated 
regarding the depth by which a particular protein could diffuse into the material. The 
lowest molecular protein, apolipoprotein A-II, was able to diffuse throughout the entire 
large pore material. Interestingly, albumin penetration was nearly identical for both the 
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large and small pore material, indicating that the increase in pore diameter had less of an 
effect on the adsorption of higher molecular weight proteins. Unsurprisingly, the highest 
molecular weight protein complement C3c, exhibited poor adsorption on both materials.  
 This methodology was then extended to binary systems to observe if 
apolipoprotein A-II demonstrated a competitive advantage over other proteins. In 
addition to albumin and complement C3c, 10 % human serum was also spiked with 
fluorescently labelled apolipoprotein A-II. In all cases, apolipoprotein A-II was able to 
completely diffuse throughout both materials, with nearly identical depths to the previous 
results. Intriguingly, when administered in concert with apolipoprotein A-II, albumin 
revealed a very different adsorption profile, in both localization and penetration. 
Complement C3c, on the other hand, once again demonstrated poor adsorption.    
The work presented in this manuscript signifies a fundamental study on the 
relationship between the physicochemical chemical properties of dense and mesoporous 
silica and the composition and identity of the protein corona. As highlighted in Chapters 
2 and 3, mesoporous silica particles exhibit an affinity for low molecular weight proteins, 
many of which are also present in low physiological concentrations. It was also shown 
that modifying the surface of these materials with various chemical moieties resulted in 
different adsorption patterns and concentrations. This unique behaviour could be of great 
importance in future diagnostic and treatment programs; by simply adjusting certain 
physicochemical properties of the materials, i.e. surface charge, particle size, particle 
shape, or pore size, predictive protein fingerprints could be used to diagnose a variety of 
diseases. While the isolation of particular proteins and biomolecules from complex 
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mixtures, such as serum, can be incredibly difficult and cost prohibitive, engineered 
nanoparticles could be used as a cheap and effective alternative to sequester these 
biomolecular markers. 
Furthermore, the methodology presented in Chapter 4 could easily be used to 
study protein adsorption in real time. Many of the current methods and tools rely on the 
isolation of protein-particle complexes prior to analysis. Thus, perturbations to the 
complex caused by the isolation method or time between analyses are disregarded. 
However, the ability to visually study protein adsorption in real time would drastically 
improve our understanding of this complex process, by providing the means to record 
kinetic rates and competitive binding processes. One might also envision the ability to 
observe and study the soft corona, an entity that has remained incredibly challenging to 
investigate.  
Success of mesoporous materials in biomedical applications can be easily found 
throughout the literature.  However, given the infancy in our understanding of one of the 
most fundamental processes, it remains challenging to assess the true impact of these 
findings. It is my hope that the work contained within this manuscript, in addition to the 
wealth of research that is currently being done on this process will aid in developing safer 
and more effective particle-based therapies. 
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